货号:A272688 同义名: Rosuvastatin hemicalcium;ZD 4522 Calcium
Rosuvastatin Calcium is a competitive and synthetic HMG-CoA reductase inhibitor with IC50 value of 11 nM.
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | HMG-CoA reductase (HMGCR) catalyzes the rate-limiting step in cholesterol biosynthesis. Rosuvastatin calcium is a potent inhibitor of HMGCR with an Ki value of 0.1 nM and an IC50 value of 5.4 nM. The cholesterol synthesis in hepatocytes was inhibited by rosuvastatin calcium with an IC50 value of 0.2 nM. Rosuvastatin calcium also shows high affinity for liver-specific organic anio transport proteins (OATPs). The apparent Km value for the interaction between rosuvastatin calcium and OATP-C was 7.3 μM[3]. In papillary thyroid carcinoma B-CPAP cells, rosuvastatin calcium at 12.5 – 200 μM decreased cell viability with IC50 values of 12.9 μM and 4.6 μM for 48h- and 72h- incubations, respectively. Treatment with 50 μM rosuvastatin calcium for 48 hours led to G1 phase arrest in B-CPAP cells with a subG1 cell peak. Rosuvastatin calcium at 12.5 – 200 μM also caused a gradual decrease in the number of B-CPAP cells and an increase of the number of vacuoles at a dose-dependent manner. The caspase-3 activity and apoptotic rate in B-CPAP cells were significantly increased by rosuvastatin calcium at 12.5 μM[4]. Oral administration of rosuvastatin calcium in rats inhibited hepatic cholesterol synthesis with an ED50 of 0.8 mg/kg as measured 2 to 3 hours post treatment[3]. |
作用机制 | Rosuvastatin calcium contains a dihydroxy heptenoic acid chain that mimics the HMG portion of HMGCR[3]. |
Dose | Rat: 0.2 mg/kg - 20 mg/kg[3] (i.p.) |
Administration | i.p. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01241903 | Acute Coronary Syndrome ... 展开 >> Angioplasty, Transluminal, Percutaneous Coronary Hydroxymethylglutaryl-CoA Reductase Inhibitors Blood Platelets 收起 << | Phase 1 | Completed | - | United States, Kentucky ... 展开 >> University of Kentucky Dept of Cardiology Lexington, Kentucky, United States, 40536 收起 << |
NCT01241903 | - | Completed | - | - | |
NCT00747149 | Type 2 Diabetes | Phase 4 | Completed | - | - |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.00mL 0.20mL 0.10mL |
4.99mL 1.00mL 0.50mL |
9.99mL 2.00mL 1.00mL |
CAS号 | 147098-20-2 |
分子式 | C44H54CaF2N6O12S2 |
分子量 | 1001.137 |
别名 | Rosuvastatin hemicalcium;ZD 4522 Calcium;ZD 4522;Rosuvastatin (calcium salt) |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Inert atmosphere,Store in freezer, under -20°C |
溶解度 |
DMSO: 25 mg/mL(24.97 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 1 mg/mL(1 mM),配合低频超声助溶 |
动物实验配方 |
4% DMSO+30% PEG 300+dd water 10 mg/mL |
Tags: Rosuvastatin | 147098-20-2 | Rosuvastatin hemicalcium | ZD 4522 | ZD4522 | ZD-4522 | HMGCR Inhibitor | Metabolic Enzyme/Protease | Autophagy | Membrane Transporter/Ion Channel | Anti-infection | HMG-CoA Reductase (HMGCR) | Autophagy | Potassium Channel | Bacterial | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Rosuvastatin Calcium 纯度/质量文件 | Rosuvastatin Calcium 生物活性 | Rosuvastatin Calcium 动物研究 | Rosuvastatin Calcium 临床数据 | Rosuvastatin Calcium 参考文献 | Rosuvastatin Calcium 实验方案 | Rosuvastatin Calcium 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01241903 | Acute Coronary Syndrome ... 展开 >> Angioplasty, Transluminal, Percutaneous Coronary Hydroxymethylglutaryl-CoA Reductase Inhibitors Blood Platelets 收起 << | Phase 1 | Completed | - | United States, Kentucky ... 展开 >> University of Kentucky Dept of Cardiology Lexington, Kentucky, United States, 40536 收起 << |
NCT01241903 | - | Completed | - | - | |
NCT00747149 | Type 2 Diabetes | Phase 4 | Completed | - | - |
NCT00747149 | - | Completed | - | - | |
NCT03192579 | Coronary Artery Disease Progre... 展开 >>ssion 收起 << | Phase 4 | Completed | - | - |
NCT02289430 | Healthy | Phase 1 | Completed | - | - |
NCT02737319 | Nephropathy | Phase 4 | Completed | - | Brazil ... 展开 >> Instituto Dante Pazzanese de Cardiologia São Paulo, Brazil, 04012-909 收起 << |
NCT02502110 | Paroxysmal Atrial Fibrillation | Phase 4 | Not yet recruiting | June 2019 | - |
NCT01068626 | Abdominal Obesity | Phase 3 | Completed | - | Sweden ... 展开 >> Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothernburg Gothenburg, Sweden, 413 45 收起 << |
NCT01068626 | - | Completed | - | - | |
NCT01526317 | Pharmacokinetics and Drug Inte... 展开 >>raction of Crestor and Glucodown SR 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital, Yonsei University Seoul, Korea, Republic of, 120-752 收起 << |
NCT02305862 | Arteriosclerosis ... 展开 >> Diabetes Mellitus Lipid Disorder 收起 << | Not Applicable | Unknown | July 2017 | China ... 展开 >> Beijing Tiantan Hospital, Capital Medical University Recruiting Beijing, China, 100050 Contact: Qiang Fu, Dr 861067096562 fuqiang66882000@hotmail.com Principal Investigator: Buxing Chen, Dr 收起 << |
NCT02962323 | Healthy Subjects | Phase 1 | Completed | - | - |
NCT01992211 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02962310 | Healthy Subjects | Phase 1 | Completed | - | - |
NCT02283515 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT02047175 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> The catholic university of Korea, seoul ST.Mary's hospital Seoul, Gangnam-gu, Korea, Republic of 收起 << |
NCT01524653 | Venous Thromboembolism ... 展开 >> Deep Vein Thrombosis Neoplasms 收起 << | Phase 2 | Completed | - | United States, Vermont ... 展开 >> Fletcher Allen Health Care Burlington, Vermont, United States, 05401 收起 << |
NCT03037372 | HIV Infection | Phase 3 | Not yet recruiting | December 31, 2022 | - |
NCT01364220 | Stroke | Phase 3 | Terminated(Slow enrollment) | - | Korea, Republic of ... 展开 >> Department of Neurology, Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Department of Neurology Colleage of Medicine Dong-A University Busan, Korea, Republic of Department of Neurology Pusan National University Hospital Busan, Korea, Republic of Department of Neurology, College of Medicine Inje University, Paik Hospital Busan, Korea, Republic of Department of Neurology, Fatima hospital Changwon, Korea, Republic of Department of Neurology, Samsung Changwon hospital Changwon, Korea, Republic of Department of Neurology, Dongsan Medical Center, Keimyung University School of Medicine Daegu, Korea, Republic of Department of Neurology, Yeungnam University School of Medicine Daegu, Korea, Republic of Department of Neurology Konyang University Hospital Daejon, Korea, Republic of Department of Neurology, Chonnam National University Hospital GwangJu, Korea, Republic of Department of Neurology, Chosun University Hospital Gwangju, Korea, Republic of Department of Neurology, Inha University Hospital Incheon, Korea, Republic of Department of Neurology, National health insurance corporation ilsan Hospital Koyang-shi, Korea, Republic of Department of Neurology, Severance Hospital Seoul, Korea, Republic of, 120-752 Department of Neurology Gangnam Severance Hospital Seoul, Korea, Republic of Department of Neurology Kyung Hee University East-West Neo Medical Center Seoul, Korea, Republic of Department of Neurology Seoul National University Hospital Seoul, Korea, Republic of Department of Neurology St. Mary's Hospital, Catholic University Seoul, Korea, Republic of Department of Neurology, Ewha Womans University Hospital Seoul, Korea, Republic of Department of Neurology, Hallym University Medical Center Seoul, Korea, Republic of Department of Neurology, Korean University Guro hospital Seoul, Korea, Republic of Department of Neurology, Kyung Hee University, College of Medicine Seoul, Korea, Republic of Department of Neurology, National Medical Center Seoul, Korea, Republic of Department of Neurology, Samsung Medical Center Seoul, Korea, Republic of Department of Neurology, University of Ulsan,Asan Medical Center Seoul, Korea, Republic of Department of Neurology,Sanggye Paik Hospital, Inje University College of Medicine Seoul, Korea, Republic of Department of Neurology, Wonju Christian Hospital Wonju, Korea, Republic of 收起 << |
NCT02030054 | Coronary Artery Disease | Phase 4 | Unknown | September 2015 | Italy ... 展开 >> Sapienza Univeristy of Rome Not yet recruiting Rome, Italy, 00166 Contact: MD MARINA POLACCO, medicine +393333347960 dott.mpolacco@gmail.com Principal Investigator: MD Marina Polacco, medicine 收起 << |
NCT00885872 | Hyperlipidemia ... 展开 >> Atherosclerosis 收起 << | Phase 4 | Unknown | March 2012 | China, Beijing ... 展开 >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Du Ruixue, Dr. 13693578338 drx1972@hotmail.com 收起 << |
NCT03044873 | Autoimmune Diseases ... 展开 >> Inflammatory Diseases 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> PPD Phase I Clinic Austin, Texas, United States, 78744 收起 << |
NCT02420899 | Acute Coronary Syndrome | Not Applicable | Unknown | July 2016 | China, Beijing ... 展开 >> Liu Qingbo Recruiting Beijing, Beijing, China, 100050 Contact: Qingbo Liu, master 13552328830 1035105896@qq.com 收起 << |
NCT02483871 | Breast Cancer | Phase 1 | Withdrawn(Enrollment did not m... 展开 >>eet anticipated goals. Eligibility was a challenge.) 收起 << | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT03156842 | Essential Hypertension ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Recruiting | May 1, 2019 | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of 收起 << |
NCT02125227 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Jeonju-si, Jeollabuk-do, Korea, Republic of, 561712 收起 << |
NCT01218802 | HIV Infections ... 展开 >> Heart Disease 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> University Hospitals of Cleveland Case Medical Center Cleveland, Ohio, United States, 44106 收起 << |
NCT02484027 | Infarction, Anterior Cerebral ... 展开 >>Artery 收起 << | Phase 4 | Unknown | September 2018 | China, Jiangsu ... 展开 >> Department of Neurology, Second Affiliated Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China, 215004 Contact: Chun-Feng Liu, Ph.D, M.D. 00 86 512 67783307 liucf@suda.edu.cn Principal Investigator: Yong-Jun Cao, Ph.D, M.D. Principal Investigator: Wan-Qing Zhai, M.D Sub-Investigator: Xia Zhang, M.D. 收起 << |
NCT03217409 | Diabetes Mellitus and Hypercho... 展开 >>lesterolemia 收起 << | Phase 4 | Recruiting | July 2018 | Korea, Republic of ... 展开 >> Soon Chun Hyang University Hospital Cheonan Recruiting Cheonan, Korea, Republic of Soon Chun Hyang University Hospital Gumi Recruiting Gumi, Korea, Republic of Soon Chun Hyang University Hospital Bucheon Recruiting Gyeonggi-do, Korea, Republic of Soon Chun Hyang University Hospital Seoul Recruiting Seoul, Korea, Republic of 收起 << |
NCT00653588 | Hypercholesterolemia ... 展开 >> Coronary Heart Disease 收起 << | Phase 3 | Completed | - | - |
NCT01218802 | - | Completed | - | - | |
NCT00228514 | Rosuvastatin ... 展开 >>Heart Failure Positron Emission Tomography (PET) 收起 << | Phase 3 | Completed | - | Netherlands ... 展开 >> Research Site Groningen, Netherlands 收起 << |
NCT02859480 | Coronary Artery Disease ... 展开 >> Coronary Disease Cardiovascular Diseases 收起 << | Phase 4 | Recruiting | December 2019 | Korea, Republic of ... 展开 >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 02841 Contact: Hyung Joon Joo, MD, PhD +8229205445 drjoohj@gmail.com 收起 << |
NCT00653445 | Hypercholesterolemia ... 展开 >> Coronary Heart Disease Atherosclerosis 收起 << | Phase 3 | Completed | - | - |
NCT03116516 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Recruiting | December 2017 | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of, 561-712 Contact: Mingul Kim, MD 收起 << |
NCT00680017 | Dyslipidemia ... 展开 >>Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT02314286 | Severe Pre-eclampsia | Phase 1 Phase 2 | Unknown | July 2016 | - |
NCT00680017 | - | Completed | - | - | |
NCT01982461 | Hypercholesterolemia | Not Applicable | Unknown | - | Taiwan ... 展开 >> Tri-Service General Hospital Recruiting Taipei, Taiwan, 11490 Contact 886-2-87923311 ext 10552 tsghirb@ndmctsgh.edu.tw 收起 << |
NCT01874743 | HIV-1 Infection | Phase 2 | Unknown | September 2013 | France ... 展开 >> St Antoine Hospital Recruiting Paris, France, 75012 Contact: pauline Campa, MD 49283044 ext +331 pauline.campa@sat.aphp.fr Principal Investigator: Pierre-Marie Girard, PHD,MD HEGP Recruiting Paris, France, 75015 Contact: Laurence Weiss, PHD,MD 56093299 ext +331 laurence.weiss@egp.aphp.fr Principal Investigator: Laurence Weiss, PHD,MD 收起 << |
NCT00344123 | HIV Infections | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21287 收起 << |
NCT02341794 | Intracranial Arterial Diseases | Not Applicable | Unknown | July 2018 | Japan ... 展开 >> Tokyo Medical University Recruiting Shinjuku-ku, Tokyo, Japan, 160-8402 Principal Investigator: Daisuke Nishi, M.D., Ph.D. 收起 << |
NCT02317016 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | United States, Virginia ... 展开 >> Research Site Fairfax, Virginia, United States, 22031 France Research Site Bordeaux Cedex, France, 33075 Research Site Bordeaux Cedex, France, 33076 Research Site Montpellier, France, 34298 Research Site Rennes, France, 35033 Spain Research Site Barcelona, Spain, 08036 Research Site Madrid, Spain, 28007 Research Site Málaga, Spain, 29010 Research Site Sevilla, Spain, 41013 Research Site Sevilla, Spain, 41071 United Kingdom Research Site London, United Kingdom, EC1A 7BE Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT01469416 | Healthy | Phase 1 | Completed | - | United States, California ... 展开 >> Clinical Research Center, UCSF San Francisco, California, United States, 94143 收起 << |
NCT02317016 | - | Completed | - | - | |
NCT02772640 | Hypercholesterolemia | Phase 4 | Unknown | December 2016 | Poland ... 展开 >> Cardiology Department, Dr. A. Jurasz University Hospital Recruiting Bydgoszcz, Kujawsko-Pomorskie, Poland, 85-094 Contact: Karolina Obońska, MD, PhD +48 52 5854023 kalaobonska@op.pl 收起 << |
NCT02387619 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Yonsei University Health System Seoul, Seodaemun-gu, Korea, Republic of, 120-752 收起 << |
NCT02029625 | Dyslipidemia | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Kyungpook National Hospital Jung-gu, Daegu, Korea, Republic of, 700-721 收起 << |
NCT00815659 | Metabolic Syndrome | Phase 4 | Completed | - | Turkey ... 展开 >> Research site Ankara, Besevler, Turkey Research site Kayseri, Erciyes, Turkey Research site Istanbul, Haseki, Turkey Research site Kocaeli, Umuttepe, Turkey Research Site Izmir, Turkey Research Site Trabzon, Turkey 收起 << |
NCT01929512 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT02574845 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Boehringer Ingelheim Investigational Site Biberach, Germany 收起 << |
NCT00815659 | - | Completed | - | - | |
NCT02951962 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 收起 << |
NCT00240318 | Coronary Arteriosclerosis | Phase 3 | Completed | - | - |
NCT02574845 | - | Completed | - | - | |
NCT02546323 | Atherosclerosis | Phase 3 | Active, not recruiting | January 31, 2019 | China ... 展开 >> Research Site Beijing, China, 100035 Research Site Beijing, China, 100050 Research Site Beijing, China, 100191 Research Site Beijing, China, 100853 Research Site Bengbu, China, 233060 Research Site Changsha, China, 410011 Research Site Chongqin, China, 400042 Research Site Guangzhou, China, 510080 Research Site Guangzhou, China, 510120 Research Site Guangzhou, China, 510260 Research Site Guangzhou, China, 510515 Research Site Guangzhou, China, 510630 Research Site Haerbin, China, 150001 Research Site Nanchang, China, 330006 Research Site Nanjing, China, 210009 Research Site Ningbo, China, 315010 Research Site Shanghai, China, 200032 Research Site Shanghai, China, 200065 Research Site Shanghai, China, 200090 Research Site Shenyang, China, 110001 Research Site Tianjin, China, 300457 Research Site Wenzhou, China, CN-325000 Research Site Wuhan, China, 430022 Research Site Xian, China, 710061 收起 << |
NCT02418884 | Coronary Artery Disease | Phase 4 | Unknown | March 2018 | - |
NCT00885495 | HIV Infections | Phase 1 Phase 2 | Unknown | August 2009 | United States, Ohio ... 展开 >> University of Cincinnati AIDS Clinical Trials Unit Cincinnati, Ohio, United States, 45267 收起 << |
NCT00225589 | Hypercholesteremia | Phase 3 | Completed | - | - |
NCT03026933 | Dyslipidemias | Phase 3 | Completed | - | - |
NCT01918709 | Hypertension, Hyperlipidemia | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial Center, Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT00984932 | Systemic Sclerosis | Phase 3 | Completed | - | Egypt ... 展开 >> Faculty of Medicine, University of Alexandria Alexandria, Egypt, 203 收起 << |
NCT03677297 | Adult Periodontitis | Phase 4 | Completed | - | India ... 展开 >> Sukhada Deo Pune, Maharashtra, India, 411018 收起 << |
NCT00966472 | Squamous Cell Carcinoma ... 展开 >> Non-Small Cell Lung Cancer 收起 << | Phase 1 | Completed | - | Canada, Ontario ... 展开 >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 收起 << |
NCT02299245 | Telomere Shortening ... 展开 >> Telomere Length, Mean Leukocyte 22q Telomere Deletion Syndrome 收起 << | Phase 4 | Unknown | November 2016 | - |
NCT02185963 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of 收起 << |
NCT02532309 | Carotid Atherosclerosis | Phase 4 | Unknown | - | China, Beijing ... 展开 >> China-Japan Friendship Hospital Recruiting Beijing, Beijing, China Contact: Liu Wei, Ph.D 63483495@qq.com Contact: Jiao Jinsong, Professor jiaojinsong@aliyun.com Principal Investigator: Liu Wei, Ph.D 收起 << |
NCT02011633 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT02077257 | Acute Coronary Syndrome | Phase 4 | Unknown | May 2016 | China, Beijing ... 展开 >> Beijing Anzhen Hospital Recruiting Beijing, Beijing, China Contact: Changsheng Ma, PhD 收起 << |
NCT02364258 | Dyslipidemia | Phase 1 | Recruiting | December 2017 | United States, Missouri ... 展开 >> Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Jon Wagner, DO 816-234-3000 ext 59373 jbwagner@cmh.edu Principal Investigator: Jon B Wagner, DO 收起 << |
NCT03019549 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Covance Clinical Research Inc Daytona Beach, Florida, United States, 32117 收起 << |
NCT00660764 | - | Completed | - | - | |
NCT01975194 | Stroke Transi... 展开 >>ent Ischemic Attack 收起 << | Phase 4 | Terminated(loss of research pe... 展开 >>rsonnel) 收起 << | - | United States, Michigan ... 展开 >> Detroit Medical Center Detroit, Michigan, United States, 48201 收起 << |
NCT02104843 | Hepatitis C | Phase 1 | Completed | - | - |
NCT01775579 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samgsung Seoul Hospital Seoul, Korea, Republic of 收起 << |
NCT03699774 | Drug Pharmacokinetics in Healt... 展开 >>hy Volunteers 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> Worldwide Clinical Trials (WCT) Early Phase Services San Antonio, Texas, United States, 78217 收起 << |
NCT01899027 | Arterial Hypertension | Phase 4 | Unknown | December 2017 | Italy ... 展开 >> University Sapienza Not yet recruiting Rome, Italy, 00161 Contact: Cesare Greco, MD +390649971 ext 123 cesare.greco@uniroma1.it Contact: Francesco Pelliccia, MD +390649971 ext 123 f.pelliccia@mclink.it Principal Investigator: Francesco Pelliccia, MD 收起 << |
NCT00986999 | HIV Infections ... 展开 >> Cardiovascular Disease 收起 << | Phase 2 Phase 3 | Terminated(poor enrollment) | - | United States, Hawaii ... 展开 >> Hawaii Center for AIDS Honolulu, Hawaii, United States, 96813 收起 << |
NCT01299038 | Breast Cancer | Phase 2 | Active, not recruiting | December 2018 | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT02101125 | Immunosuppression For Disease | Phase 1 | Completed | - | United States, Texas ... 展开 >> Healthcare Discoveries, Llc D/B/A Icon Development Solutions San Antonio, Texas, United States, 78209 收起 << |
NCT01389388 | Carotid Artery Plaque ... 展开 >> Ankylosing Spondylitis Rheumatoid Arthritis 收起 << | Not Applicable | Completed | - | Norway ... 展开 >> Anne Grete Semb, Department of Rheumatology, Diakonhjemmet hospital Oslo, Norway, NO-0319 收起 << |
NCT00986999 | - | Terminated(poor enrollment) | - | - | |
NCT01382277 | Hyperlipidemia ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Unknown | April 2013 | China, Beijing ... 展开 >> Peking University First Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Yanjun Gong, MD 86-10-83572299 gongyanjun111@163.com China Division of Cardiology, Peking University First Hospital Recruiting Beijing, China, 100034 Contact: Jie Jiang, MD 86-10-66551383 收起 << |
NCT01968577 | Coronary Artery Disease | Phase 4 | Unknown | December 2013 | Brazil ... 展开 >> Instituto Dante Pazzanese de Cardiologia Recruiting Sao Paulo, Brazil, 04012-180 Contact: AMANDA S GUERRA, DIRECTOR 55-11-5085-6000 diretoriageral@dantepazzanese.org.br Principal Investigator: KLEBER B A MARTINS, MD 收起 << |
NCT02026817 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT03359291 | Healthy Subjects | Phase 1 | Completed | - | Germany ... 展开 >> CRS Clinical Research Services Mannheim Mannheim, Germany, 68167 收起 << |
NCT02593487 | Hyperlipemia ... 展开 >>Coronary Heart Disease 收起 << | Phase 4 | Unknown | June 2017 | China, Chongqing ... 展开 >> Xu-kai Wang Not yet recruiting Chongqing, Chongqing, China, 400042 Contact: Qing-kai Yan, MD +8618623457875 yanqingkai@hotmail.com Contact: Peng Cai, MD +8602368757810 doubleboy1987@sina.com 收起 << |
NCT01613729 | Dyslipidemia | Phase 4 | Unknown | December 2013 | Bangladesh ... 展开 >> BSMMU Dhaka, Bangladesh, 1000 收起 << |
NCT03169985 | Coronary Artery Disease | Phase 4 | Recruiting | December 31, 2023 | Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Joo-Yong Hahn, MD, PhD 82-2-3410-6653 ichjy1@gmail.com Contact: Joo Myung Lee, MD, MPH 82-2-3410-1246 drone80@hanmail.net 收起 << |
NCT02594800 | Atherosclerosis | Phase 4 | Unknown | March 28, 2018 | China, Zhejiang ... 展开 >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Min Lou, Ph.D 13958007213 z2loumin@163.com 收起 << |
NCT02083627 | Drug-Drug Interaction (DDI) ... 展开 >> Intestinal Absorption Healthy Subjects Pharmacokinetics of Rosuvastatin Pharmacokinetics of Fidaxomicin 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Parexel GmbH Berlin, Germany, D-14059 收起 << |
NCT03007524 | Acute Coronary Syndrome | Phase 4 | Recruiting | December 2019 | China, Jiangsu ... 展开 >> Nanjing First Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210006 Contact: Zhang Yao-Jun, MD Contact: Zhu Yong-Xiang, MSC 收起 << |
NCT01751074 | Atherosclerosis | Phase 1 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Glendale, California, United States, 91206 收起 << |
NCT00463606 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00463606 | - | Completed | - | - | |
NCT01490398 | Hypertension ... 展开 >>Cardiovascular Risk Factors 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << |
NCT03175835 | Dyslipidemias | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT02284503 | Non-ST-elevation Acute Coronar... 展开 >>y Syndromes 收起 << | Phase 4 | Unknown | June 2016 | China, Shanghai ... 展开 >> Zhongshan Hospital Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Yinman Wang, Master +86 21 64041990 ext 2521 wang.yinman@zs-hospital.sh.cn Principal Investigator: Junbo Ge, MD 收起 << |
NCT00766025 | CYP2C19 Poor ... 展开 >>Extensive Metabolizers 收起 << | Phase 1 | Completed | - | Taiwan ... 展开 >> Research Site Taipei, Taiwan 收起 << |
NCT02106767 | Healthy | Phase 1 | Unknown | March 2016 | United States, California ... 展开 >> CTSI Clinical Research Center, UCSF San Francisco, California, United States, 94143 收起 << |
NCT02705547 | Friedreich Ataxia | Early Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19103 收起 << |
NCT01863914 | End-stage Kidney Disease ... 展开 >> Diabetes Mellitus Arteriovenous Fistula 收起 << | Phase 2 | Recruiting | December 2018 | Taiwan ... 展开 >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chen-Fuh Lam, MD, PhD 8866-2353535 ext 5348 lamcf@mail.ncku.edu.tw Principal Investigator: Chen-Fuh Lam, MD, PhD Sub-Investigator: Jun-Neng Roan, MD 收起 << |
NCT02215174 | Statin Pharmacokinetics Pre an... 展开 >>d Post Gastric Bypass Surgery 收起 << | Phase 1 | Unknown | - | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Hsin-Fang Wu, PhD candidate 415-476-5890 hf.wu@ucsf.edu Contact: Leslie Benet, PhD 415-476-5890 leslie.benet@ucsf.edu Principal Investigator: Leslie Benet, PhD Taiwan E-Da Hospital Not yet recruiting Kaohsiung, Taiwan, 82445 Contact: Cheng-Fang Chiu, Master +886912370601 ed105456@edah.org.tw Contact: Chih-Kun Huang, M.D +886-7-6150011 ext 3036 dr.ckhuang@hotmail.com Sub-Investigator: Chih-Kun Huang, M.D 收起 << |
NCT01218347 | Organic Anion Transporting Pol... 展开 >>ypeptide1B1 (OATP1B1) Rosuvastatin 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT01524601 | Disorder Related to Renal Tran... 展开 >>splantation Hypercholesterolemia 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Oslo University Hospital, Rikshospitalet Oslo, Norway, 0027 收起 << |
NCT03715101 | Elderly | Phase 1 | Completed | - | - |
NCT01466608 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-799 收起 << |
NCT02569645 | Rectal Cancer | Phase 2 | Recruiting | May 2021 | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 收起 << |
NCT03216304 | Healthy | Phase 1 | Completed | - | Switzerland ... 展开 >> CROSS Research SA, Phase I Unit Arzo, Ticino, Switzerland, 6864 收起 << |
NCT00554138 | Adenosine Metabolism | Not Applicable | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB 收起 << |
NCT01923077 | Acute Myocardial Infarction | Phase 2 | Unknown | September 2013 | Denmark ... 展开 >> OUH/Svendborg Hospital Svendborg, Funen, Denmark, 5700 收起 << |
NCT02800902 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 收起 << |
NCT00114491 | - | Completed | - | Portugal ... 展开 >> Hospital Pedro Hispano Porto, Portugal 收起 << | |
NCT01964365 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University College of Medicine Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT00695539 | - | Completed | - | Greece ... 展开 >> Research Site Alexandroupoli, Greece Research Site Athens, Greece Research Site Iraklio, Crete, Greece Research Site Larissa, Greece Research Site Rio, Patra, Greece Research Site Thessaloniki, Greece 收起 << | |
NCT03446261 | Type 2 Diabetes Mellitus ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Not yet recruiting | April 2019 | Korea, Republic of ... 展开 >> Asan Medical Center Not yet recruiting Seoul, Korea, Republic of Inje University Sanggye Paik Hospital Not yet recruiting Seoul, Korea, Republic of Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of Konkuk University Medical Center Not yet recruiting Seoul, Korea, Republic of Kyung Hee University Hospital at Gangdong Not yet recruiting Seoul, Korea, Republic of 收起 << |
NCT00487136 | Healthy | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Site Ref # / Investigator 5290 Little Rock, Arkansas, United States, 72205 收起 << |
NCT00379249 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01609907 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Yuhan Corporation Seoul, Korea, Republic of 收起 << |
NCT03403556 | Atherosclerotic Cardiovascular... 展开 >> Disease Type 2 Diabetes 收起 << | Phase 4 | Not yet recruiting | February 2019 | Korea, Republic of ... 展开 >> Daegu Catholic University Medical Center Not yet recruiting Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Not yet recruiting Daegu, Korea, Republic of Kyungpook National University Hospital Not yet recruiting Daegu, Korea, Republic of Yeungnam University Medical Center Not yet recruiting Daegu, Korea, Republic of The Catholic University of Korea, St. Vincent's Hospital Not yet recruiting Gyeonggi-do, Korea, Republic of Korea University Anam Hospital Not yet recruiting Seoul, Korea, Republic of 收起 << |
NCT00800800 | Aortic Stenosis | Phase 3 | Completed | - | Canada, Alberta ... 展开 >> Research site Calgary, Alberta, Canada Research site Edmonton, Alberta, Canada Canada, British Columbia Research site Surrey, British Columbia, Canada Research site Vancouver, British Columbia, Canada Research site Victoria, British Columbia, Canada Canada, Manitoba Research site Edmonton, Manitoba, Canada Canada, Ontario Research site Brampton, Ontario, Canada Research site Cambridge, Ontario, Canada Research site Kitchener, Ontario, Canada Research site Montreal, Ontario, Canada Research site Ottawa, Ontario, Canada Research site Toronto, Ontario, Canada Canada, Quebec Research site Montreal, Quebec, Canada Canada Research site Halifax, Canada Research site St. John's, Canada 收起 << |
NCT01425398 | Valvular Cardiac Surgery | Phase 3 | Unknown | November 2013 | Canada, Quebec ... 展开 >> Royal Victoria Hospital Not yet recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Jennifer Chung, M.D. 438-886-3901 jennifer.chung2@mail.mcgill.ca Principal Investigator: Jennifer Chung, M.D. Principal Investigator: Benoit De Varennes, M.D. Principal Investigator: Jacques Genest, M.D. Sub-Investigator: Peter Goldberg, M.D. 收起 << |
NCT01831479 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT03494270 | ASCVD | Phase 4 | Recruiting | December 2019 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: In-ho Chae 82-31-787-7012 ihchae@snu.ac.kr 收起 << |
NCT02675309 | Healthy | Phase 1 | Completed | - | United Kingdom ... 展开 >> Investigational center City name, United Kingdom 收起 << |
NCT00653965 | Hypercholesterolemia ... 展开 >> Dyslipidaemia 收起 << | Phase 3 | Completed | - | - |
NCT02645227 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Government Dental College and Research Institute Bangalore, Karnataka, India, 560002 收起 << |
NCT00315510 | Ischemia | Phase 2 | Completed | - | Netherlands ... 展开 >> Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB 收起 << |
NCT00176332 | Heart Failure | Phase 2 | Completed | - | Germany ... 展开 >> University of Leipzig, Heart Center, Department of Internal Medicine / Cardiology Leipzig, Saxony, Germany, 04289 收起 << |
NCT02082665 | Cancer | Phase 1 | Completed | - | United States, New Hampshire ... 展开 >> GSK Investigational Site Lebanon, New Hampshire, United States, 03756 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Sevilla, Spain, 41013 收起 << |
NCT02280590 | Hyperlipidemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00951132 | Depression | Phase 2 | Unknown | December 2010 | Norway ... 展开 >> Akershus University Hospital Recruiting Lorenskog, Akershus, Norway, 1478 Contact: Gunnar Einvik, MD 41104542 ext +47 gunnar.einvik@medisin.uio.no 收起 << |
NCT00355615 | - | Completed | - | - | |
NCT03204058 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00355615 | Familial Hypercholesterolemia | Phase 3 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States United States, New York Research Site Hyde Park, New York, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Pennsylvania Research Site Wexford, Pennsylvania, United States Canada, Ontario Research Site Hamilton, Ontario, Canada Research Site Toronto, Ontario, Canada Canada, Quebec Research Site Chicoutimi, Quebec, Canada Research Site Laval, Quebec, Canada Research Site Sherbrook, Quebec, Canada Netherlands Research SIte Amsterdam, Netherlands Research Site Eindhoven, Netherlands Research Site Groningen, Netherlands Research Site Hoorn, Netherlands Research Site Rotterdam, Netherlands Research Site Utrecht, Netherlands Research SIte Waalwijk, Netherlands Norway Research Site Oslo, Norway Spain Research Site Cordoba, Spain Research Site Madrid, Spain Research Site Reus, Spain 收起 << |
NCT00929734 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 2 | Completed | - | Norway ... 展开 >> Akershus University Hospital Lørenskog, Akershus, Norway, 1478 收起 << |
NCT01526460 | Platelet Dysfunction | Phase 2 | Completed | - | Italy ... 展开 >> IRCCS San Raffaele Monte Tabor Milan, Italy, 20132 收起 << |
NCT03597412 | Atherosclerotic Cardiovascular... 展开 >> Disease Type 2 Diabetes Mellitus 收起 << | Phase 4 | Not yet recruiting | March 30, 2020 | Korea, Republic of ... 展开 >> Kangbuk Samsung Hospital Not yet recruiting Seoul, Korea, Republic of 收起 << |
NCT01414803 | Hyperlipidemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT02079506 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Chungnam National University Hospital Jung-gu, Daejeon, Korea, Republic of, 301-721 收起 << |
NCT00929734 | - | Completed | - | - | |
NCT00851175 | Atherosclerosis ... 展开 >> Cardiovascular Disease 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> RUNMC Nijmegen, Netherlands, 6525 GA 收起 << |
NCT00631189 | Type IIa and IIb Hypercholeste... 展开 >>rolaemia 收起 << | Phase 4 | Completed | - | - |
NCT00689416 | Atherosclerosis ... 展开 >> Inflammatory Activity in Carotid Arteries 收起 << | Early Phase 1 | Completed | - | Sweden ... 展开 >> Research Site Uppsala, Sweden 收起 << |
NCT01164397 | - | Completed | - | Mexico ... 展开 >> Research Site Mexico, DF, Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Cuernavaca, Morelos, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Veracruz, Xalapa, Mexico Research Site Merida, Yucatan, Mexico Research Site Durango, Mexico Research Site Puebla, Mexico Research Site San Luis Potosi, Mexico 收起 << | |
NCT00555230 | Rheumatoid Arthritis | Phase 2 | Completed | - | China ... 展开 >> School of Pharmacy CUHK Hong Kong, China 收起 << |
NCT01918358 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT02205190 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 收起 << |
NCT00654394 | Carotid Artery Stenosis ... 展开 >> Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT00585143 | Dyslipidemia, Renal Insufficie... 展开 >>ncy 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Site Reference ID/Investigator# 6610 Gainesville, Florida, United States, 32608 Site Reference ID/Investigator# 6738 Miami, Florida, United States, 33136 United States, Minnesota Site Reference ID/Investigator# 7723 Minneapolis, Minnesota, United States, 55404 United States, Tennessee Site Reference ID/Investigator# 7319 Knoxville, Tennessee, United States, 37920 United States, Texas Site Reference ID/Investigator# 6928 San Antonio, Texas, United States, 78209 United States, Virginia Site Reference ID/Investigator# 8280 Richmond, Virginia, United States, 23298-0160 收起 << |
NCT01646307 | Focus of Study | Phase 4 | Unknown | June 2013 | China ... 展开 >> Beijing Anzhen Hospital Recruiting Beijing, China, 100029 Sub-Investigator: Ying-Xin Zhao, MD Principal Investigator: Yu-Jie Zhou, MD, PhD 收起 << |
NCT00631189 | - | Completed | - | - | |
NCT00295373 | Nonfamilial Hypercholesterolem... 展开 >>ia Physical Inactivity 收起 << | Phase 4 | Unknown | August 2007 | United States, Indiana ... 展开 >> Purdue University West Lafayette, Indiana, United States, 47906 收起 << |
NCT00688454 | - | Completed | - | - | |
NCT03187496 | NASH | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Pharmaceutical Research Associates, Inc., Lenexa, Kansas, United States, 66219 收起 << |
NCT02233218 | Healthy Male Volunteer | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Dong-A university hospital Pusan, Korea, Republic of 收起 << |
NCT01921946 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 收起 << |
NCT00786136 | Diabetes Mellitus ... 展开 >> Chronic Kidney Disease 收起 << | Phase 4 | Completed | - | - |
NCT01653119 | Acute Coronary Syndrome ... 展开 >> Diabetes Mellitus 收起 << | Not Applicable | Unknown | December 2015 | China, Beijing ... 展开 >> Peking University Third Hospital Recruiting Beijing, Beijing, China, 100191 Contact: Wei Gao, Master +8613901366179 dr_gaowei@medmail.com.cn Contact: Wei Zhao, Doctor +8618600017812 beate_vv@bjmu.edu.cn 收起 << |
NCT02397538 | Hypertension | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of, Korea, Republic of 收起 << |
NCT01863225 | Dyslipidemia ... 展开 >>Coronary Artery Disease 收起 << | Phase 2 | Terminated | - | Australia, South Australia ... 展开 >> Royal Adelaide Hospital / CMAX Adelaide, South Australia, Australia, 5000 收起 << |
NCT02166814 | Essential Hypertension, Dyslip... 展开 >>idemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul university Bundang hospital Bundang, Korea, Republic of Dong-A university hospital Busan, Korea, Republic of Inje Heaundai Paik hospital Busan, Korea, Republic of Inje university Busan Paik hospital Busan, Korea, Republic of ChungNam university hospital ChungNam, Korea, Republic of DanGuk university hospital Chungnam, Korea, Republic of The Catholic university of Korea Daegu hospital Daegu, Korea, Republic of DongGuk university Gyeongju hospital Gyeongju, Korea, Republic of DongGuk university Ilsan hospital Ilsan, Korea, Republic of Inje university Ilsan Paik hospital Ilsan, Korea, Republic of Gachon university Gil medical center Incheon, Korea, Republic of Inha university hospital Incheon, Korea, Republic of Jeju national university hospital Jeju, Korea, Republic of JeonNam university hospital JeonNam, Korea, Republic of Kyungbook National university hospital Kyungbook, Korea, Republic of Gangnam Severance hospital Seoul, Korea, Republic of Jeil hospital Seoul, Korea, Republic of Korea university Anam hospital Seoul, Korea, Republic of Korea university Guro hospital Seoul, Korea, Republic of Kyunghee university hospital Seoul, Korea, Republic of Samsung Seoul hospital Seoul, Korea, Republic of Seoul national university hospital Seoul, Korea, Republic of Severance hospital Seoul, Korea, Republic of The Catholic university St. Mary hospital Seoul, Korea, Republic of Aju university hospital Suwon, Korea, Republic of YoungNam university hospital YoungNam, Korea, Republic of 收起 << |
NCT00654407 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01573143 | Atrial Fibrillation ... 展开 >> Myocardium; Injury 收起 << | Phase 4 | Completed | - | China, Beijing ... 展开 >> Fuwai Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100037 收起 << |
NCT00651378 | Hypercholesterolemia ... 展开 >> Atherosclerosis Coronary Artery Disease 收起 << | Phase 4 | Terminated(Slow enrollment [HI... 展开 >>GH SCREEN FAILURE RATE]) 收起 << | - | - |
NCT03088254 | Dyslipidemia With Hypertension | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Chungnam National University Hospital Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Seoul National University Bundang Hospital Gyeonggi-do, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of KyungHee University Hospital at Gangdong Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of SoonChunHyang University Hospital, Seoul Seoul, Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul, Korea, Republic of 收起 << |
NCT03074630 | Diabetes Mellitus, Type 2 ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Academic Medical Center Amsterdam, North Holland, Netherlands, 1105AZ 收起 << |
NCT03753477 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT01798602 | H1N1 Influenza | Phase 2 | Terminated(H1N1 pandemic concl... 展开 >>uded) 收起 << | - | Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 收起 << |
NCT00240331 | Renal Failure | Phase 3 | Completed | - | - |
NCT02608242 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Terminated(sponsor decision) | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Chunju, Korea, Republic of, 561-712 收起 << |
NCT00240331 | - | Completed | - | - | |
NCT02300363 | Healthy | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Lexicon Investigational Site Evansville, Indiana, United States, 47710 收起 << |
NCT02106845 | Neoplasms | Phase 1 | Active, not recruiting | December 31, 2018 | Germany ... 展开 >> Freiburg, Baden-Württemberg, Germany, 79106 Frankfurt, Hessen, Germany, 60488 Herne, Nordrhein-Westfalen, Germany, 44625 Hungary Budapest, Hungary, 1083 Budapest, Hungary, 1122 收起 << |
NCT02611518 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Berlin, Germany 收起 << |
NCT00913562 | Glaucoma Diab... 展开 >>etes 收起 << | Phase 4 | Withdrawn | - | Austria ... 展开 >> Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria, 1090 收起 << |
NCT01007279 | Periprocedural Myocardial Necr... 展开 >>osis 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> Policlinico Umberto I Rome, Italy, 00166 收起 << |
NCT00505154 | Dilated Cardiomyopathy | Phase 3 | Completed | - | Norway ... 展开 >> Oslo University Hospital Oslo, Norway 收起 << |
NCT01929070 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung medical center Seoul, Korea, Republic of 收起 << |
NCT01228227 | Assess the Periprocedural Myoc... 展开 >>ardial Necrosis 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> Policlinico Umberto I Roma, Italy 收起 << |
NCT01795937 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> 1220.61.1 Boehringer Ingelheim Investigational Site Ingelheim, Germany 收起 << |
NCT01795937 | - | Completed | - | - | |
NCT02369250 | Furcation Defects | Phase 4 | Completed | - | - |
NCT00473655 | Hypertriglyceridemia ... 展开 >> Hyperlipoproteinemia Type IV Hyperlipoproteinemia Type V Hyperlipoproteinemia Type IIb Hyperlipidemia 收起 << | Phase 4 | Completed | - | Mexico ... 展开 >> Research Site Mexico City, DF, Mexico Research Site Guadalajara, Jalisco, Mexico Research Site Monterrey, Nuevo Leon, Mexico 收起 << |
NCT00329160 | Hypercholesteremia | Phase 4 | Completed | - | Japan ... 展开 >> Research Site Gifu, Japan Research Site Hamada, Japan Research Site Hiroshima, Japan Research Site Ichinomiya, Japan Research Site Inba-mura, Japan Research Site Izumisano, Japan Research Site Izumi, Japan Research Site Izumo, Japan Research Site Kagoshima, Japan Research Site Kanazawa, Japan Research Site Kasuga, Japan Research Site Kobe, Japan Research Site Komaki, Japan Research Site Konan-cho, Japan Research Site Kumamoto, Japan Research Site Kurume, Japan Research Site Kyoto, Japan Research Site Omiya, Japan Research Site Osaka, Japan Research Site Sapporo, Japan Research Site Shinjo, Japan Research Site Shunan, Japan Research Site Suita, Japan Research Site Tokyo, Japan Research Site Ube, Japan Research Site Yamaguchi, Japan Research Site Yokohama, Japan 收起 << |
NCT01058915 | Acute Coronary Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 收起 << |
NCT00371579 | Hepatitis C | Not Applicable | Withdrawn(no actual patients r... 展开 >>ecruited within year 1 after ethical committee approval) 收起 << | October 2007 | Netherlands ... 展开 >> University Medical Center Utrecht Utrecht, Netherlands, 3584 CX 收起 << |
NCT00329160 | - | Completed | - | - | |
NCT00335699 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Research Site DaeGu, Korea, Republic of Research Site IkSan, Korea, Republic of Research Site JeonJu, Korea, Republic of Research Site JinJu, Korea, Republic of Research Site KwangJu, Korea, Republic of Research Site Pusan, Korea, Republic of Research Site Ulsan, Korea, Republic of 收起 << |
NCT02089061 | Acute Coronary Syndromes | Phase 1 | Completed | - | - |
NCT02626234 | cMET-dysregulated Advanced Sol... 展开 >>id Tumors 收起 << | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Emory University School of Medicine/Winship Cancer Institute Phase 1 Working Group Atlanta, Georgia, United States, 30322 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Austria Novartis Investigative Site Vienna, Austria, A-1090 Belgium Novartis Investigative Site Edegem, Belgium, 2650 Czechia Novartis Investigative Site Brno, Czechia, 65653 Greece Novartis Investigative Site Ioannina, GR, Greece, 455 00 Novartis Investigative Site Athens, Greece, 18547 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Bologna, Italy, 40138 Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site London, United Kingdom, W1G 6AD Novartis Investigative Site Manchester, United Kingdom, M20 9BX 收起 << |
NCT01936805 | Atherosclerosis | Phase 3 | Completed | - | Turkey ... 展开 >> Yuksek Ihtisas Hospital Ankara, Altindag, Turkey, 06100 收起 << |
NCT01185938 | Acute Coronary Syndrome | Phase 4 | Completed | - | Italy ... 展开 >> Cardiology Division, Prato Hospital Prato, Italy, 59100 收起 << |
NCT02127320 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of, Korea, Republic of 收起 << |
NCT01547377 | Dietary Selenium Deficiency ... 展开 >> Dietary Zinc Deficiency 收起 << | Not Applicable | Completed | - | Brazil ... 展开 >> Onofre Lopes University Hospital Natal, Rio Grande do Norte, Brazil, 59.012.300 收起 << |
NCT02434497 | Homozygous Familial Hyperchole... 展开 >>sterolemia (HoFH) 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Research Site Brussels (Woluwé-St-Lambert), Belgium, 1200 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Denmark Research Site Copenhagen, Denmark, DK-2100 Israel Research Site Halfa, Israel, 31096 Malaysia Research Site Kubang Kerian, Malaysia, 16150 Taiwan Research Site Taipei City, Taiwan, 11217 收起 << |
NCT02434497 | - | Completed | - | - | |
NCT01971606 | A Total of 234 Patients With A... 展开 >>cute Coronary Syndrome Who Will Undergo OPCAB. 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Division of Cardiovascular Surgery, Severance Cardiovascular Hospital , Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 收起 << |
NCT02117453 | ANCA-associated Primary Necrot... 展开 >>izing Vasculitides 收起 << | Phase 3 | Active, not recruiting | April 2020 | France ... 展开 >> Hopital Cochin Paris, France, 75014 收起 << |
NCT00240305 | Metabolic Syndrome ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Completed | - | Australia, Western Australia ... 展开 >> Research Site Perth, Western Australia, Australia 收起 << |
NCT01245894 | Myocardial Infarction [C14.907... 展开 >>.585.500] 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 收起 << |
NCT02234882 | HIV Infections | Phase 1 | Completed | - | - |
NCT01548157 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT00206310 | Heart Failure | Phase 3 | Completed | - | - |
NCT02140489 | Healthy | Phase 1 | Unknown | August 2014 | Korea, Republic of ... 展开 >> Samgsung Seoul Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: JaeWook Ko, M.D. 收起 << |
NCT00473655 | - | Completed | - | - | |
NCT00241488 | Hypercholesterolemia | Phase 3 | Completed | - | China ... 展开 >> Beijing, China Ching Qing, China Guang Zhou, China Harbin, China Ji Nan, China Nanjing, China Shanghai, China Shenyang, China Wu Han, China Hong Kong New Territories, Hong Kong Korea, Republic of Busan, Korea, Republic of Cheonan-si, Korea, Republic of Daegu, Korea, Republic of Ilsan, Korea, Republic of Incheon-Si, Korea, Republic of Kwangju, Korea, Republic of Pusan, Korea, Republic of Pyungchon Kyonggi, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Wonju, Korea, Republic of Malaysia Kuching, Sarawak, Malaysia Bandar Sunway, Selangor, Malaysia Shah Alam, Selangor, Malaysia Kuala Lumpur, Malaysia Penang, Malaysia Petaling Jaya, Malaysia Seberang Perai Utara, Malaysia Taiwan Chunghua City, Taiwan Kaohsiung, Taiwan Taichung City, Taiwan Taipei, Taiwan Tao-Yuan, Taiwan Thailand Bangkok, Thailand 收起 << |
NCT03532139 | Ovarian Cancer | Phase 2 | Recruiting | May 31, 2024 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Rachel P Rosovsky, MD RPROSOVSKY@PARTNERS.ORG Principal Investigator: Rachel P. Rosovsky, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jeffrey Zwicker, MD 617-975-7454 jzwicker@bidmc.harvard.edu Principal Investigator: Jeffrey Zwicker, MD 收起 << |
NCT01223625 | Endothelial Dysfunction ... 展开 >> Atherosclerosis 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 收起 << |
NCT00396240 | Primary Hypercholesterolaemia | Phase 4 | Withdrawn(study cancelled prio... 展开 >>r to FSI) 收起 << | - | - |
NCT03245229 | Healthy Subjects | Phase 1 | Completed | - | Czechia ... 展开 >> Cepha s.r.o Plzen, Czechia, 32300 收起 << |
NCT03526367 | Contrast-induced Acute Kidney ... 展开 >>Injury ST Elevation Myocardial Infarction Primary PCI Rosuvastatin Hydration 收起 << | Phase 4 | Not yet recruiting | December 31, 2019 | China, Liaoning ... 展开 >> The General Hospital of Shenyang Millitary Region Not yet recruiting Shenyang, Liaoning, China Contact: Yaling Han, MD +86-024-28856123 hanyaling@263.net Contact: Yi Li, MD +86-024-28897309 doctorliyi@126.com 收起 << |
NCT00979121 | - | Terminated(stopped for futilit... 展开 >>y) 收起 << | - | - | |
NCT01203982 | ST-segment Elevation Myocardia... 展开 >>l Infarction Subclinical Carotid Atherosclerosis 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Cardiology, Odense University Hospital Odense, Fuenen, Denmark, 5000 收起 << |
NCT00979121 | Sepsis Acute ... 展开 >>Lung Injury 收起 << | Phase 3 | Terminated(stopped for futilit... 展开 >>y) 收起 << | - | - |
NCT01021488 | Deep Vein Thrombosis ... 展开 >> Venous Thrombosis Prevention 收起 << | Phase 4 | Unknown | March 2012 | Korea, Republic of ... 展开 >> Hallym University Sacred Heart Hospital, Department of Cardiology and Orthopedic Surgery Recruiting Anyang-si, Gyeonggi-do, Korea, Republic of, 431-070 Contact: Sang-Ho Jo, MD 82-31-380-3722 sophi5@medimail.co.kr Contact: mikyung Baek 82-31-380-1975 mikyungb@hallym.or.kr 收起 << |
NCT03516955 | - | Completed | - | - | |
NCT03540355 | Dyslipidemias | Phase 3 | Not yet recruiting | January 30, 2020 | - |
NCT02371603 | Anaemia | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT03527069 | Hypertriglyceridemia ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Not yet recruiting | January 30, 2020 | - |
NCT00970606 | Acute Respiratory Distress Syn... 展开 >>drome Influenza H1N1 Influenza 收起 << | Not Applicable | Terminated(Inability to recrui... 展开 >>t participants since H1N1 epidemic resolved.) 收起 << | - | - |
NCT02704702 | - | Completed | - | - | |
NCT02704702 | Hypertension | Phase 1 | Completed | - | - |
NCT02749994 | Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00347217 | - | Completed | - | - | |
NCT02458755 | Stroke Intrac... 展开 >>ranial Atherosclerosis 收起 << | Phase 4 | Unknown | June 2018 | Korea, Republic of ... 展开 >> Oh Young Bang Recruiting Seoul, Korea, Republic of, 135-710 Contact: Oh Young Bang, MD, PhD +82-2-3410-3599 ohyoungbang@samsung.com Contact: Jong-Won Chung, MD, Msc +82-10-9032-9906 neurocjw@gmail.com 收起 << |
NCT03395470 | Metabolic Disease | Phase 1 | Completed | - | United Kingdom ... 展开 >> Hammersmith Medicines Research (HMR) London, United Kingdom 收起 << |
NCT02600520 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT00970606 | - | Terminated(Inability to recrui... 展开 >>t participants since H1N1 epidemic resolved.) 收起 << | - | - | |
NCT00728780 | Adverse Events ... 展开 >> Pharmacokinetic Variables 收起 << | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Site Reference ID/Investigator# 11101 Evansville, Indiana, United States, 47710 收起 << |
NCT00866229 | Systemic Lupus Erythematosus ... 展开 >> High LDL Cholesterol Level 收起 << | Phase 4 | Unknown | June 2010 | Thailand ... 展开 >> Faculty of Medicine, Ramathibodi Hospital, Mahidol University Recruiting Bangkok, Thailand, 10240 Contact: Pintip Ngamjanyaporn, M.D. +6622011477 pintiptip@yahoo.com Contact: Piyaporn Sirijanchun, M.D. +6622011477 tepsrc@mahidol.ac.th Principal Investigator: Parawee Suwannalai, M.D. 收起 << |
NCT01033955 | Critically Ill ... 展开 >> H1N1/Influenza Infection 收起 << | Phase 2 | Terminated(H1N1 pandemic concl... 展开 >>uded in early 2010) 收起 << | - | Canada, British Columbia ... 展开 >> Vancouver General Hospital Vancouver, British Columbia, Canada, V5Z 1M9 St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Health Sciences Centre Winnipeg, Manitoba, Canada, R3B 0Z3 Canada, Ontario St. Joseph's Healthcare Hamilton, Ontario, Canada, L8N 4A6 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Hopital Laval Quebec City, Quebec, Canada, G1V 4G5 Centre hospitalier universitaire de Sherbrooke (CHUS) Sherbrooke, Quebec, Canada, J1H 5N4 收起 << |
NCT00526721 | - | Completed | - | Korea, Republic of ... 展开 >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of 收起 << | |
NCT00240344 | - | Completed | - | - | |
NCT03742544 | - | Enrolling by invitation | October 30, 2020 | - | |
NCT02854527 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Boehringer Ingelheim Pharma GmbH & Co KG Biberach, Germany, 88397 收起 << |
NCT00396110 | - | Completed | - | - | |
NCT02854527 | - | Completed | - | - | |
NCT02913794 | - | Unknown | March 30, 2018 | Korea, Republic of ... 展开 >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Dong-Hoon Choie cdhlyj@yuhs.ac 收起 << | |
NCT01415466 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of 收起 << |
NCT00526708 | - | Completed | - | Korea, Republic of ... 展开 >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of 收起 << | |
NCT00184951 | HIV Infections ... 展开 >> Hyperlipidemia 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> University of Bonn Bonn, Germany University of Cologne Cologne, Germany Netherlands University of Amsterdam Amsterdam, Netherlands University of Leiden Leiden, Netherlands University of Nijmegen Nijmegen, Netherlands 收起 << |
NCT01200836 | - | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << | |
NCT01582165 | Angina Pectoris | Phase 4 | Completed | - | Norway ... 展开 >> Oslo University Hospital, Dep of Cardiology, Rikshospitalet Oslo, Norway, 0380 收起 << |
NCT00526552 | - | Completed | - | Korea, Republic of ... 展开 >> Research Site Seoul, Jongro-gu, Korea, Republic of Research Site Seoul, Kangnam-gu, Korea, Republic of Research Site Seoul, Songpa-gu, Korea, Republic of 收起 << | |
NCT00525824 | - | Completed | - | - | |
NCT02561845 | - | Withdrawn | October 2015 | - | |
NCT03571087 | Primary Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00525824 | Hypercholesterolemia ... 展开 >> Coronary Heart Disease Atherosclerosis 收起 << | Phase 3 | Completed | - | United States, Tennessee ... 展开 >> Research Site Brentwood, Tennessee, United States Argentina Research Site Buenos Aires, Argentina Brazil Research Site Sao Paulo, SP, Brazil Chile Research Site Santiago, Chile Colombia Research Site Brentwood, Colombia Lithuania Research Site Brentwood, Lithuania Netherlands Research Site Zwinderen, Netherlands Peru Research Site Lima, San Isidro Lima, Peru Venezuela Research Site Brentwood, Venezuela 收起 << |
NCT02205775 | Stable Coronary Artery Disease... 展开 >> Undergoing PCI 收起 << | Phase 3 | Terminated(difficult recruitme... 展开 >>nt) 收起 << | - | Italy ... 展开 >> SS. Annunziata Hospital Chieti, CH, Italy, 66100 Fondazione IRCCS Policlinico S. Matteo Pavia, PV, Italy, 27100 A.O. S. Anna e S. Sebastiano - II Università di Napoli Caserta, Italy, 81100 Azienda ASL 6 - P. Ospedaliero Livorno Livorno, Italy, 57100 Ospedale Civile G. Fornaroli Magenta, Italy, 20013 Azienda Ospedaliera - Ospedale San Paolo Milano, Italy, 20142 收起 << |
NCT00233649 | - | Completed | - | - | |
NCT01823900 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT01352897 | - | Completed | - | Singapore ... 展开 >> Research Site Singapore, Singapore 收起 << | |
NCT00826358 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Site Reference ID/Investigator# 13441 Orlando, Florida, United States, 32809 收起 << |
NCT00574782 | - | Completed | - | - | |
NCT00837083 | - | Completed | - | - | |
NCT03311841 | Renal Insufficiency | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami ( Site 0001) Hialeah, Florida, United States, 33014 Orlando Clinical Research Center ( Site 0002) Orlando, Florida, United States, 32809 收起 << |
NCT01494090 | Hip Fracture | Phase 3 | Terminated(Decision of the Ste... 展开 >>ering Committee. Recruitment more difficult and slower than expected.) 收起 << | - | France ... 展开 >> Brest, University Hospital Brest, France Caen, University Hospital Caen, France Grenoble, University Hospital Grenoble, France APHP - Cochin Hospital Paris, France Quimper Hospital Quimper, France St-Etienne, University Hospital St-Etienne, France 收起 << |
NCT03757390 | Healthy Subjects | Phase 1 | Recruiting | December 14, 2018 | Korea, Republic of ... 展开 >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of 收起 << |
NCT01953835 | Systemic Lupus Erythematosus | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT00808678 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Site Reference ID/Investigator# 14762 Orlando, Florida, United States, 32809 收起 << |
NCT03363815 | Heathy Volunteer | Phase 1 | Not yet recruiting | February 23, 2018 | United States, Florida ... 展开 >> Covance Clinical Research Unit Not yet recruiting Daytona Beach, Florida, United States, 32117 收起 << |
NCT01914432 | Hyperlipidemia ... 展开 >> Hypertension 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT01816997 | Diabetes | Phase 4 | Recruiting | December 2022 | Taiwan ... 展开 >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD 886-2-28757515 Principal Investigator: Harn-Shen Chen, MD, PhD 收起 << |
NCT01051401 | Cardiovascular Complications ... 展开 >> Recurrent Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer 收起 << | Phase 1 | Terminated(slow accrual) | - | United States, North Carolina ... 展开 >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT03639493 | Healthy Male Subjects | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT02087540 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 3 | Unknown | - | Korea, Republic of ... 展开 >> The Catholic University of Saint Mary's Hosiptal Recruiting Seoul, Korea, Republic of Contact: wook-seong chung, MD chungws@catholic.ac.kr Principal Investigator: wook-seong Chung, MD 收起 << |
NCT01544309 | Hypercholesterolemia With Conc... 展开 >>omitant Type 2 Diabetes 收起 << | Not Applicable | Completed | - | - |
NCT01178853 | - | Completed | - | - | |
NCT01178853 | Healthy | Phase 4 | Completed | - | United States, Texas ... 展开 >> Austin, Texas, United States 收起 << |
NCT01881971 | HIV Seropositivity | Early Phase 1 | Completed | - | United States, California ... 展开 >> University of California, Los Angelos Los Angeles, California, United States, 90095 University of California, SF San Francisco, California, United States, 94118 United States, Pennsylvania University of Pittsburgh department of medicine division of Pulmonary, Allergy and Critical Care medicine Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT00549653 | Atherosclerosis ... 展开 >> Cardiovascular Disease 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Dallas, Texas, United States, 75247 收起 << |
NCT01544309 | - | Completed | - | - | |
NCT01660191 | Hypercholesterolemia | Phase 4 | Completed | - | United States, Kansas ... 展开 >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 收起 << |
NCT00388596 | Osteoporosis | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 收起 << |
NCT00783042 | Atherosclerosis ... 展开 >> Inflammatory Activity in Coronary Arteries 收起 << | Early Phase 1 | Completed | - | Sweden ... 展开 >> Research Site Goteborg, Sweden 收起 << |
NCT01660191 | - | Completed | - | - | |
NCT00693589 | Cardiovascular Disease ... 展开 >> Endothelial Dysfunction 收起 << | Phase 2 | Completed | - | - |
NCT00296387 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT02445352 | Primary Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seodaemun-gu, Seoul, Korea, Republic of, 120-752 收起 << |
NCT03329729 | - | Recruiting | January 30, 2019 | Greece ... 展开 >> Agia Olga Hospital Recruiting Athens, Greece Contact: Sotirios Patsilinakos, MD 收起 << | |
NCT02707224 | Healthy | Phase 1 | Completed | - | - |
NCT02089399 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung medical center Seoul, Korea, Republic of 收起 << |
NCT02841774 | HIV Infection ... 展开 >> Coronary Heart Disease 收起 << | Phase 2 | Recruiting | March 2019 | United States, Illinois ... 展开 >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Matthew Feinstein, MD matthewjfeinstein@northwestern.edu Principal Investigator: Matthew Feinstein, MD 收起 << |
NCT00934258 | - | - | - | - | |
NCT03009487 | Hypertension ... 展开 >>Hyperlipidemias 收起 << | Phase 3 | Recruiting | - | Korea, Republic of ... 展开 >> Seoul national university bundang hospital Recruiting Seoul, Korea, Republic of Contact: Wan Huh +82-2-550-8106 whuh408@daewoong.co.kr 收起 << |
NCT00923676 | Sexual Dysfunction ... 展开 >> Hyperlipidemia 收起 << | Phase 4 | Unknown | April 2016 | Italy ... 展开 >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 收起 << |
NCT02561884 | Healthy | Phase 1 | Unknown | October 2015 | - |
NCT01773512 | Coronary Artery Disease | Phase 4 | Unknown | June 2015 | United States, Illinois ... 展开 >> Loyola University Hospital Active, not recruiting Maywood, Illinois, United States, 60153 United States, Iowa The University of Iowa Active, not recruiting Iowa City, Iowa, United States, 52242 Czech Republic General University Hospital Recruiting Prague, Czech Republic, 12808 Contact: Tomas Kovarnik, MD, PhD +420224962687 tomas.kovarnik@vfn.cz Contact: Jan Horak, MD, PhD +420224962605 jan.horak@vfn.cz Principal Investigator: Tomas Kovarnik, MD, PhD Sub-Investigator: Jan Horak, MD, PhD Sub-Investigator: Hana Skalicka, MD, PhD Sub-Investigator: Ales Kral, MD, PhD Sub-Investigator: Ales Linhart, MD, professor Sub-Investigator: Pavel Martasek, MD, professor 收起 << |
NCT03434613 | Nonalcoholic Fatty Liver Disea... 展开 >>se Dyslipidemias 收起 << | Phase 4 | Not yet recruiting | September 1, 2019 | Korea, Republic of ... 展开 >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Yong-ho Lee, M.D., Ph.D. 82-2-2228-1943 yholee@yuhs.ac 收起 << |
NCT00446940 | Hepatitis C | Phase 2 | Completed | - | United States, Oklahoma ... 展开 >> VA Hospital OKlahoma City, Oklahoma, United States, 73104 收起 << |
NCT01660919 | Hypercholesterolemia | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Gil Medical Center Incheon, Korea, Republic of, 405-760 收起 << |
NCT00336336 | Heart Failure | Phase 3 | Completed | - | - |
NCT01697735 | Dyslipidemias | Phase 4 | Terminated(Because of lack of ... 展开 >>participants and funds) 收起 << | - | China, Zhejiang ... 展开 >> Second Hospital of Wenzhou Medical College Wenzhou, Zhejiang, China, 325000 收起 << |
NCT02129231 | Oxidative Stress ... 展开 >> Diabetic Polyneuropathy 收起 << | Phase 2 | Completed | - | Mexico ... 展开 >> Cardiovascular Research Unit Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01598363 | Healthy Volunteers | Phase 1 | Completed | - | United States, Wisconsin ... 展开 >> Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 收起 << |
NCT02251847 | Hypercholesterolemia | Phase 3 | Unknown | - | Korea, Republic of ... 展开 >> Gil Medical Center Recruiting Seoul, Korea, Republic of Contact: Tae Hoon Ahn 收起 << |
NCT02105623 | Coronary Arteriosclerosis | Phase 4 | Terminated(Slow enrollement, L... 展开 >>ow Follow-up rate) 收起 << | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT02748057 | Hypercholesterolemia ... 展开 >> Familial Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT02748057 | - | Completed | - | - | |
NCT00654537 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01730053 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02516826 | Coronary Syndrome | Phase 2 | Unknown | August 2018 | Korea, Republic of ... 展开 >> Cardiac and Vascular Center; Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT01730053 | - | Completed | - | - | |
NCT00329173 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT00296400 | Hyperlipidemia | Phase 2 | Completed | - | - |
NCT03009474 | Hypertension ... 展开 >>Hyperlipidemias 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 << |
NCT02569814 | Hypertension ... 展开 >>Hyperlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT02477514 | Skin Diseases, Bacterial | Phase 1 | Completed | - | - |
NCT02546648 | Atherosclerotic Disease ... 展开 >> Perioperative Bleeding 收起 << | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 Juravinski Hospital Hamilton, Ontario, Canada, L8V 1C3 收起 << |
NCT00862251 | Cardiovascular Disorder ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Completed | - | - |
NCT00862251 | - | Completed | - | - | |
NCT02789475 | Hypertension ... 展开 >>Hyperlipidemias 收起 << | Phase 1 | Unknown | July 2016 | Korea, Republic of ... 展开 >> Inha university hospital Recruiting Jung-gu, Incheon, Korea, Republic of, 400-711 Contact: Chul woo Kim, Ph.D. cwkim1805@inha.ac.kr 收起 << |
NCT01382472 | ST Elevation (STEMI) Myocardia... 展开 >>l Infarction 收起 << | Phase 4 | Unknown | December 2016 | Norway ... 展开 >> Stavanger University Hospital Recruiting Stavanger, Norway, 4068 Contact: Alf Inge Larsen, MD, PhD +4751513201 laai@sus.no Principal Investigator: Noreen Butt, MD University Hospital of North Norway Recruiting Tromsø, Norway, NO-9038 Contact: Terje Steigen, MD, PhD +4791507766 terje.steigen@unn.no Principal Investigator: Terje Steigen, MD PhD St. Olavs Hospital Not yet recruiting Trondheim, Norway, NO-7006 Contact: Rune Wiseth, MD, PhD +4772573000 rune.wiseth@ntnu.no Principal Investigator: Rune Wiseth, MD, PhD 收起 << |
NCT01153334 | ST-segment Elevation AMI | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT00296400 | - | Completed | - | - | |
NCT00296374 | Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00654602 | Dyslipidaemia | Phase 3 | Completed | - | - |
NCT01493856 | Healthy Volunteers | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Yonsei University Health System (Yuhs) Seoul, Korea, Republic of 收起 << |
NCT01288742 | Hepatitis C Virus | Phase 1 | Completed | - | - |
NCT02231931 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> 352.2082.1 Boehringer Ingelheim Investigational Site Biberach, Germany 收起 << |
NCT00296374 | - | Completed | - | - | |
NCT03174041 | Healthy Participants | Phase 1 | Completed | - | United States, Florida ... 展开 >> Covance Research Unit - Daytona Daytona Beach, Florida, United States, 32117 United States, Indiana Covance Clinical Research Unit Inc.; Covance Gfi Research Evansville, Indiana, United States, 47710 United States, Wisconsin Covance Clinical Research Unit, Inc Madison, Wisconsin, United States, 53704 收起 << |
NCT03288038 | Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Chungbuk National University Hospital Cheongju-si, Korea, Republic of Yeungnam University Medical Center Daegu, Korea, Republic of Chungnam National University Hospital Daejeon, Korea, Republic of Dongguk University Ilsan Hospital Goyang-si, Korea, Republic of Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Korea, Republic of Gachon University Gil Medical Center Incheon, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Seoul National University Bundang Hospital Seongnam-si, Korea, Republic of Boramae Hospital Seoul, Korea, Republic of Chung-Ang University Hospital Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hanyang University Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of KyungHee University Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Soon Chun Hyang University Hospital Seoul Seoul, Korea, Republic of Ajou University Hospital Suwon-si, Korea, Republic of Wonju Severance Christian Hospital Wŏnju, Korea, Republic of 收起 << |
NCT00214617 | Hypercholesterolemia | Phase 4 | Completed | - | United States, Georgia ... 展开 >> Atlanta Research and Education Foundation Decatur, Georgia, United States, 30033 收起 << |
NCT00965315 | - | - | - | - | |
NCT00214604 | Hyperlipoproteinemia Type III | Phase 3 | Completed | - | Norway ... 展开 >> Research Site Oslo, Norway South Africa Research Site Cape Town, South Africa 收起 << |
NCT00117494 | Hyperlipidemia ... 展开 >> HIV Infections 收起 << | Phase 4 | Completed | - | France ... 展开 >> service de Médecine Interne Hopital Hotel Dieu Paris, France, 75004 收起 << |
NCT00654225 | Hypercholesterolemia ... 展开 >> Dyslipidaemia 收起 << | Phase 3 | Completed | - | - |
NCT01010516 | Dyslipidemia | Phase 4 | Unknown | - | Greece ... 展开 >> University of Ioannina Medical School Recruiting Ioannina, Greece, 45 110 Contact: M S Elisaf, MD +302651007509 egepi@cc.uoi.gr Principal Investigator: Moses S Elisaf, MD Sub-Investigator: Evangelos N Liberopoulos, MD Sub-Investigator: Anastazia Kei, MD 收起 << |
NCT02518503 | - | Completed | - | - | |
NCT00680082 | - | Completed | - | - | |
NCT03011775 | Adverse Effect ... 展开 >> Atherosclerosis, Coronary Insulin Resistance Syndrome 收起 << | Phase 4 | Completed | - | Ukraine ... 展开 >> Ukrainian Medical Stomatological Academy Poltava, Ukraine, 36011 收起 << |
NCT01105325 | - | Terminated(due to poor patient... 展开 >> recruitment) 收起 << | March 2011 | - | |
NCT00718796 | Cardiovascular Disease | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Canadian College of Naturopathic Medicine Toronto, Ontario, Canada, M2K 1E2 收起 << |
NCT02305355 | Diabetes Mellitus, Type 2 ... 展开 >> Hypertriglycemia 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Bucheon St. Mary's Hospital Bucheon, Korea, Republic of 收起 << |
NCT02378064 | Inflammation Plaque, Atheroscl... 展开 >>erotic Coronary Disease Renin-Angiotensin System 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 << |
NCT01350141 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT00730132 | - | Completed | - | - | |
NCT01350141 | - | Completed | - | - | |
NCT00730132 | - | Completed | - | - | |
NCT00874757 | - | Unknown | December 2011 | United States, Nebraska ... 展开 >> UNMC College of Pharmacy Recruiting Omaha, Nebraska, United States, 68198-6045 Contact: Timothy R McGuire, Pharm.D. 402-559-8224 trmcguir@unmc.edu Contact: Paul Dobesh, Pharm.D. 402-559-1983 pdobesh@unmc.edu 收起 << | |
NCT00557778 | - | Completed | - | Brazil ... 展开 >> Research Site Campinas, Sao Paulo, Brazil 收起 << | |
NCT03355027 | Atherosclerosis ... 展开 >> Cardiovascular Diseases 收起 << | Not Applicable | Recruiting | May 8, 2019 | United Kingdom ... 展开 >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Paul Cacciottolo 01223256653 pjc99@medschl.cam.ac.uk Principal Investigator: Joseph Cheriyan, MBChB, MA, FRCP 收起 << |
NCT01901757 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT01764295 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00930670 | Coronary Artery Disease | Phase 4 | Completed | - | Canada, Quebec ... 展开 >> Institut Universitaire de Cardiologie et de Pneumologie de Quebec Quebec City, Quebec, Canada, G1V4G5 收起 << |
NCT03719820 | - | Recruiting | June 30, 2021 | China, Beijing ... 展开 >> Beijing Hospital Not yet recruiting Beijing, Beijing, China, 100010 Contact: Tao Gong 13718907701 gb20598@sina.com Beijing Tongren Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100010 Contact: Jiawei Wang 18811612263 wangjwcq@1163.com Beijing Anzhen Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100020 Contact: Guangzhi Liu 13391777952 guangzhi2002@hotmali.com Beijing Chao-Yang hospital Not yet recruiting Beijing, Beijing, China, 100020 Contact: Wenli Hu 13552983366 huwenli@sina.com China-Japan Friendship Hospital Not yet recruiting Beijing, Beijing, China, 100020 Contact: Dantao Peng 13910908579 18513415053@163.com Beijing Friendship Hospital Capital Medical University Not yet recruiting Beijing, Beijing, China, 100032 Contact: Yongbo Zhang 13552909549 ybzhangcn@sina.com Peking University First Hospital Not yet recruiting Beijing, Beijing, China, 100032 Contact: Yining Huang 13910432166 ynhuang@sina.com General Hospital of Chinese Armed Police Forces Recruiting Beijing, Beijing, China, 100039 Contact: Shiwen Wu, MD 13910238117 neurowu@gmail.com Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100730 Contact: Weihai Xu, MD 010-69156372 xuwh@pumch.cn Peking University International Hospital Not yet recruiting Beijing, Beijing, China, 102200 Contact: Xianzeng Liu 13911879817 liuxianzeng@pkuih.edu.cn China, Fujian Fujian Medical University Union Hospital Not yet recruiting Fuzhou, Fujian, China, 350001 Contact: Changyun Liu, MD 13365910778 13365910778@139.com China, Guangdong The Third Affiliated Hospital of Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510630 Contact: Zhengqi Lu 13570102668 lzq1828@aliyun.com The University of HongKong-Shenzhen Hospital Not yet recruiting Shenzhen, Guangdong, China, 518000 Contact: Xiaofan Chu chuxf@hku-szh.org China, Hebei Tangshan Gongren Hospital Recruiting Tangshan, Hebei, China, 063000 Contact: Baoquan Lu 13930565557 balcom@163.com China, Hubei Tongji Hospital, Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430000 Contact: Daishi Tian tiands@foxmail.com China, Hunan The First Affiliated Hospital of University of South China Not yet recruiting Hengyang, Hunan, China, Hunan Contact: Yong You, MD 13974709033 youy_usc@qq.com China, Jiangsu Subei People's Hospital of Jiangsu Province Not yet recruiting Yangzhou, Jiangsu, China, 225001 Contact: Jun Xu, MD 18051061768 13611572068@126.com China, Liaoning General Hospital of Shen Yang Millitary Command Not yet recruiting Shenyang, Liaoning, China, 110840 Contact: Huishen Chen, MD 13352452086 chszh@aliyun.com China, Shandong JiNing NO.1 People Hospital Not yet recruiting Jining, Shandong, China, 272000 Contact: Zhongrui Yan 18678769700 zhongruiy@163.com Qingdao Municipal Hospital Not yet recruiting Qingdao, Shandong, China, 266000 Contact: Jintai Yu yu-jintai@163.com Qilu Hospital of Shandong University (Qingdao) Not yet recruiting Qingdao, Shandong, China, 266555 Contact: Haifeng Li 18561810375 drlhf@163.com China, Shanghai Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200050 Contact: Jun Liu jly0520@hotmail.com Tongren Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200050 Contact: Ailian Du lotusdu@126.com China, Sichuan West China Hospital of Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Bo Wu dr.bowu@hotmail.com 收起 << | |
NCT03772262 | Interaction Drug Food | Early Phase 1 | Recruiting | March 31, 2019 | United States, Washington ... 展开 >> Washington State University Recruiting Spokane, Washington, United States, 99202 Contact: Malathi Jandhyala 509-335-3668 irb@wsu.edu 收起 << |
NCT00850460 | Statin Adverse Reaction | Phase 4 | Terminated(Investigator left i... 展开 >>nstitution and no PI has been found to continue the study) 收起 << | - | United States, New York ... 展开 >> Rockefeller University New York, New York, United States, 10065 收起 << |
NCT00850460 | - | Terminated(Investigator left i... 展开 >>nstitution and no PI has been found to continue the study) 收起 << | - | - | |
NCT03372785 | Chronic Total Occlusion of Cor... 展开 >>onary Artery Percutaneous Coronary Intervention Coronary Artery Disease Viable Myocardium 收起 << | Phase 4 | Enrolling by invitation | December 2020 | China ... 展开 >> Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University Beijing, China 收起 << |
NCT02767401 | Hibernation, Myocardial ... 展开 >> Complete Occlusion of Coronary Artery 收起 << | Phase 4 | Unknown | December 2018 | - |
NCT02984982 | Hypercholesterolemia ... 展开 >> Acute Coronary Syndrome 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Investigational Site Number 392026 Bunkyoku-ku, Japan Investigational Site Number 392022 Chiyoda-ku, Japan Investigational Site Number 392032 Fujisawa-shi, Japan Investigational Site Number 392004 Fukui-shi, Japan Investigational Site Number 392007 Fukuoka-shi, Japan Investigational Site Number 392048 Fukuoka-shi, Japan Investigational Site Number 392008 Gifu-shi, Japan Investigational Site Number 392039 Hiroshima-shi, Japan Investigational Site Number 392028 Isehara-shi, Japan Investigational Site Number 392036 Itabashi-ku, Japan Investigational Site Number 392037 Itabashi-ku, Japan Investigational Site Number 392024 Izumisano-shi, Japan Investigational Site Number 392013 Izunokuni-shi, Japan Investigational Site Number 392020 Kawaguchi-shi, Japan Investigational Site Number 392041 Kisarazu-shi, Japan Investigational Site Number 392009 Kitakyushu-shi, Japan Investigational Site Number 392034 Kitakyushu-shi, Japan Investigational Site Number 392044 Kochi-shi, Japan Investigational Site Number 392002 Kumamoto-shi, Japan Investigational Site Number 392011 Kumamoto-shi, Japan Investigational Site Number 392003 Kurashiki-shi, Japan Investigational Site Number 392018 Matsuyama-shi, Japan Investigational Site Number 392021 Morioka-shi, Japan Investigational Site Number 392017 Nagakute-shi, Aichi, Japan Investigational Site Number 392047 Nagaoka-shi, Japan Investigational Site Number 392038 Nagoya-shi, Japan Investigational Site Number 392042 Nagoya-shi, Japan Investigational Site Number 392033 Okayama-shi, Japan Investigational Site Number 392006 Osaka-shi, Japan Investigational Site Number 392010 Osaka-shi, Japan Investigational Site Number 392045 Osaka-shi, Japan Investigational Site Number 392046 Osaka-shi, Japan Investigational Site Number 392015 Sagamihara-shi, Japan Investigational Site Number 392019 Sakai-shi, Japan Investigational Site Number 392035 Sapporo-shi, Japan Investigational Site Number 392001 Tenri-shi, Japan Investigational Site Number 392016 Toyoake-shi, Japan Investigational Site Number 392025 Tsukuba-shi, Japan Investigational Site Number 392040 Tsukuba-shi, Japan Investigational Site Number 392005 Wakayama-shi, Japan Investigational Site Number 392027 Yokohama-shi, Japan Investigational Site Number 392043 Yokohama-shi, Japan 收起 << |
NCT01699126 | Sleep Apnea, Obstructive | Phase 4 | Completed | - | Taiwan ... 展开 >> Chang Gang Memorial Hospital Taoyuan, Taiwan, 333 收起 << |
NCT01342211 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT03561298 | Healthy Subjects | Phase 1 | Completed | - | United States, Florida ... 展开 >> Covance Clinical Research Unit Daytona Beach, Florida, United States, 32117 收起 << |
NCT01342211 | - | Completed | - | - | |
NCT03552432 | Coronary Artery Disease ... 展开 >> Thin-cap fIbroatheroma 收起 << | Phase 4 | Recruiting | September 30, 2021 | Japan ... 展开 >> Kobe University Graduate School of Medicine, Department of Cardiology Recruiting Kobe, Hyogo, Japan, 650-0017 Contact: Hiromasa Otake, MD +81783825846 hotake@med.kobe-u.ac.jp 收起 << |
NCT02390375 | Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Boramae Hospital Seoul, Dongjak-gu, Korea, Republic of, 156-707 收起 << |
NCT03720366 | Leukemia, Myeloid, Acute | Phase 1 | Not yet recruiting | December 30, 2022 | - |
NCT02586129 | Dyslipidemia ... 展开 >>Type II Diabetes 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Seoul National Universitiy Bundang Hospital Seongnam-Si, Gyeonggi-Do, Korea, Republic of, 463-707 收起 << |
NCT01623921 | Blunt Chest Trauma ... 展开 >> Acute Respiratory Distress Syndrome 收起 << | Not Applicable | Unknown | August 2013 | Israel ... 展开 >> Tel Aviv Sourasky Medical Center Not yet recruiting Tel Aviv, Israel, 64239 Contact: Avi A Weinbroum, MD 3-6973237 ext 972 draviw@tasmc.health.gov.il 收起 << |
NCT02114697 | Atherosclerosis | Phase 4 | Terminated(The study was stopp... 展开 >>ed when the original principal investigator moved to a new institution.) 收起 << | - | United States, Georgia ... 展开 >> Emory University Atlanta, Georgia, United States, 30322 收起 << |
NCT02579499 | Coronary Artery Diseasse | Phase 4 | Recruiting | March 2022 | Korea, Republic of ... 展开 >> Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: MYEONG-KI HONG, MD, Ph.D 82-2-2228-8460 MKHONG61@yuhs.ac 收起 << |
NCT02814500 | Healthy | Phase 1 | Unknown | September 2016 | - |
NCT03418974 | Dyslipidemias | Phase 4 | Active, not recruiting | December 31, 2021 | China, Beijing ... 展开 >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 收起 << |
NCT01955759 | Patients With Coronary Artery ... 展开 >>Disease Scheduled for by Pass Surgery 收起 << | Early Phase 1 | Unknown | February 2015 | Bosnia and Herzegovina ... 展开 >> Heart Center BH Not yet recruiting Tuzla, TK, Bosnia and Herzegovina, 75000 Contact: Enes Osmanović +387 66 725 744 osmanovic@bih.net.ba 收起 << |
NCT02586155 | Diabetes Mellitus, Type 2 ... 展开 >> Coronary Artery Disease Cardiovascular Diseases 收起 << | Phase 3 | Recruiting | October 2018 | Israel ... 展开 >> Lady Davis Carmel Medical Center Recruiting Haifa, Israel, 34362 Contact: Basil Lewis, MD 收起 << |
NCT02740699 | Cardiovascular Disease | Phase 4 | Recruiting | December 15, 2020 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << |
NCT02114697 | - | Terminated(The study was stopp... 展开 >>ed when the original principal investigator moved to a new institution.) 收起 << | - | - | |
NCT02449187 | Diabetes Hype... 展开 >>rlipidemia 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inha University Hospital Incheon, Korea, Republic of 收起 << |
NCT03532854 | Healthy Male Volunteers | Phase 1 | Not yet recruiting | September 18, 2018 | Korea, Republic of ... 展开 >> LG chem Not yet recruiting Seoul, Gangseo-Gu, Korea, Republic of, 07795 Contact: Subin Lee 02-6987-4153 leesubin@lgchem.com 收起 << |
NCT00240357 | Hypercholesterolemia | Phase 4 | Withdrawn(Study cancelled prio... 展开 >>r to FSI) 收起 << | - | - |
NCT02549846 | Ischemic Stroke | Phase 4 | Completed | - | Japan ... 展开 >> Hyogo collage of Medicine Nishinomiya, Hyogo, Japan, 665-8501 收起 << |
NCT03136237 | Hereditary Angioedema | Phase 1 | Completed | - | United Kingdom ... 展开 >> Covance CRU Leeds, United Kingdom, LS2 9LH 收起 << |
NCT00371501 | Atherosclerosis ... 展开 >> Thromboembolism Systemic Lupus Erythematosus 收起 << | Phase 4 | Completed | - | Hong Kong ... 展开 >> Tuen Mun Hospital Hong Kong, Hong Kong 收起 << |
NCT02785874 | HCC | Not Applicable | Terminated(insufficient for th... 展开 >>e fund) 收起 << | - | Taiwan ... 展开 >> WanFangHospital Taipei, Taiwan, 116 收起 << |
NCT02977065 | Dyslipidemias | Phase 2 | Completed | - | Australia ... 展开 >> Not provided Adelaide, Australia 收起 << |
NCT03210532 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Sevrance Hospital Seoul, Korea, Republic of 收起 << |
NCT02592317 | Prostatic Neoplasms, Castratio... 展开 >>n-Resistant 收起 << | Phase 1 | Active, not recruiting | August 1, 2019 | Moldova, Republic of ... 展开 >> Chisinau, Moldova, Republic of Spain Barcelona, Spain Sevilla, Spain 收起 << |
NCT01489943 | Crohn's Disease | Phase 1 | Completed | - | United States, New York ... 展开 >> GSK Investigational Site Buffalo, New York, United States, 14202 收起 << |
NCT01634906 | Hyperlipidemia ... 展开 >> Atherosclerosis 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Sint Franciscus Gasthuis Rotterdam, Zuid Holland, Netherlands, 3004 BA 收起 << |
NCT03550859 | Chronic Kidney Disease ... 展开 >> Proteinuria 收起 << | Phase 4 | Not yet recruiting | June 2019 | Korea, Republic of ... 展开 >> Korea University Ansan Hospital Not yet recruiting Ansan, Korea, Republic of 收起 << |
NCT02770261 | Hypertension ... 展开 >>Cholesterolemia 收起 << | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Korea University Guro Hospital Seoul, Korea, Republic of 收起 << |
NCT00090298 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01624857 | Coronary Heart Disease | Phase 3 | Unknown | June 2014 | China, Beijing ... 展开 >> China National Center for Cardiovascular Diseases Recruiting Beijing, Beijing, China, 100037 Contact: Zhe Zheng, M.D., Ph.D. 8610-8839-6051 zhengzhefuwai@tom.com Principal Investigator: Zhe Zheng, M.D., Ph.D. 收起 << |
NCT00767130 | - | Unknown | December 2009 | United States, California ... 展开 >> University of California-San Francisco Recruiting San Francisco, California, United States, 94110 Contact: Alan H.B. Wu, PhD (415) 206-3540 wualan@labmed2.ucsf.edu Principal Investigator: Alan H.B. Wu, PhD United States, Connecticut Hartford Hospital Recruiting Hartford, Connecticut, United States, 06102 Contact: Richard L. Seip, PhD 860-545-5005 rseip@harthosp.org Principal Investigator: Paul D. Thompson, M.D. United States, New York Rogosin Institute, New York Presbyterian Hospital Recruiting New York, New York, United States, 10021 Contact: Chioma Okoro 212-702-9600 ext 105 cokoro@mail.rockefeller.edu Contact: Bruce Gordon, M.D. Principal Investigator: Bruce Gordon, M.D. 收起 << | |
NCT02709187 | Healthy | Phase 1 | Completed | - | - |
NCT00464503 | Statin Induced Proteinuria | Not Applicable | Completed | - | Belgium ... 展开 >> University of Antwerp Antwerp, Belgium, 2610 收起 << |
NCT02741245 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02741245 | - | Completed | - | - | |
NCT01173939 | Hypercholesterolemia ... 展开 >> Type 2 Diabetes Hypertension 收起 << | Not Applicable | Terminated(With recommendation... 展开 >> from IDMC, Steering Committee terminated this trial due to ethical concerns raised by J-ART study.) 收起 << | - | - |
NCT00854503 | Type 2 Diabetes ... 展开 >> Diabetic Dyslipidemia 收起 << | Phase 3 | Completed | - | Italy ... 展开 >> University of Rome Tor Vergata Rome, Italy, 00133 收起 << |
NCT00300430 | Dyslipidemia ... 展开 >>Coronary Heart Disease Mixed Dyslipidemia 收起 << | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Global Medical Information North Chicago, Illinois, United States, 60064 收起 << |
NCT00300430 | - | Completed | - | - | |
NCT02428374 | Myocardial Fibrosis | Phase 4 | Recruiting | July 2019 | Brazil ... 展开 >> Hospital Sao Paulo - UNIFESP Recruiting Sao Paulo, Brazil, 04040001 Contact: Francisco A H Fonseca, MD, PhD +5511992639082 fahfonseca@terra.com.br 收起 << |
NCT02968160 | Metabolic Syndrome | Phase 4 | Recruiting | July 2018 | Korea, Republic of ... 展开 >> Dongguk University Medical Center Recruiting Ilsan, Korea, Republic of, 10326 收起 << |
NCT03255044 | Heart Failure | Phase 4 | Recruiting | May 2019 | Egypt ... 展开 >> Ain Shams University Hospital Cardiology Rehab Unit Recruiting Cairo, Egypt Contact: Hazem Khorshid, PhD +201227442219 hazemkhorshid@yahoo.com Principal Investigator: Nouran Omar, MSc 收起 << |
NCT02401256 | Healthy | Phase 4 | Completed | - | United States, Indiana ... 展开 >> Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 收起 << |
NCT02401256 | - | Completed | - | - | |
NCT02612714 | Sexual Dysfunction | Phase 4 | Completed | - | Taiwan ... 展开 >> Chang Gung Kaohsiung, Taiwan, 83349 收起 << |
NCT00462748 | - | Completed | - | - | |
NCT02411903 | Cerebral Infarction ... 展开 >> Clopidogrel,Poor Metabolism of (Disorder) 收起 << | Phase 4 | Unknown | August 2016 | - |
NCT00462748 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01105975 | Dyslipidemia | Phase 2 | Completed | - | - |
NCT02901067 | Wounds and Injuries ... 展开 >> Venous Thromboembolism 收起 << | Phase 2 | Recruiting | December 2021 | United States, Colorado ... 展开 >> Denver Health Medical Center Recruiting Denver, Colorado, United States, 80204 Principal Investigator: Ernest E. Moore, M.D. 收起 << |
NCT00987974 | Ischemia Reperfusion Injury ... 展开 >> Endothelial Dysfunction 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> RUNMC Nijmegen, Netherlands, 6500HB 收起 << |
NCT01870466 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT01023607 | Coronary Artery Disease ... 展开 >> Hyperlipidemia 收起 << | Phase 4 | Completed | - | China, Heilongjiang ... 展开 >> The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150081 收起 << |
NCT01105975 | - | Completed | - | - | |
NCT01730040 | - | Completed | - | - | |
NCT01730040 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00487318 | Chronic Hepatitis C | Phase 2 | Completed | - | United States, Oklahoma ... 展开 >> Veterans Administration Medical Center Oklahoma City, Oklahoma, United States, 73104 收起 << |
NCT03044665 | Cardiovascular Diseases ... 展开 >> Cerebrovascular Disease Peripheral Atherosclerotic Disease 收起 << | Not Applicable | Recruiting | February 15, 2022 | Korea, Republic of ... 展开 >> Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Yang-Soo Jang, MD, PhD 收起 << |
NCT02008786 | Coronary Artery Dissection, Sp... 展开 >>ontaneous 收起 << | Phase 4 | Recruiting | June 2021 | Canada, British Columbia ... 展开 >> Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Tara L Sedlak, MD 604-875-5487 Tara.Sedlak@vch.ca Principal Investigator: Jacqueline Saw, MD Principal Investigator: Tara Sedlak, MD 收起 << |
NCT01011127 | - | Completed | - | Korea, Republic of ... 展开 >> Gil Medical Center Incheon, Korea, Republic of, 405-760 收起 << | |
NCT02685462 | Healthy | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami, Florida, United States 收起 << |
NCT00479713 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT03521700 | Renal Artery Obstruction ... 展开 >> Stents Lipids Glomerular Filtration Rate Blood Pressure 收起 << | Phase 2 Phase 3 | Completed | - | China, Beijing ... 展开 >> Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing, China, 010 收起 << |
NCT03515772 | - | Recruiting | October 31, 2019 | Switzerland ... 展开 >> Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Catia Marzolini, PhD +41 77 454 92 28 Catia.Marzolini@usb.ch Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Switzerland, 1011 Contact: Perrine Courlet +41 21 314 42 60 perrine.courlet@chuv.ch 收起 << | |
NCT00719693 | Pharmacokinetic Variables | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Site Reference ID/Investigator# 9242 Evansville, Indiana, United States, 47710 收起 << |
NCT00479713 | - | Completed | - | - | |
NCT02933658 | Hypertension and Dyslipidemia | Phase 1 | Completed | - | - |
NCT02730689 | Healthy Volunteers | Phase 1 | Completed | - | - |
NCT01420549 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Completed | - | Brazil ... 展开 >> Universidade Federal de São Paulo São Paulo, Brazil, 040249000 收起 << |
NCT01154036 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00262548 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Mexico ... 展开 >> Research site Cuernavaca, Morelos, Mexico 收起 << |
NCT01154036 | - | Completed | - | - | |
NCT00491530 | Mixed Dyslipidemia | Phase 3 | Completed | - | United States, Illinois ... 展开 >> Medical Information Specialist Abbott Park, Illinois, United States, 60064 收起 << |
NCT03307252 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> CTC North GmbH & Co. KG, Hamburg Hamburg, Germany, 20251 收起 << |
NCT00811356 | Malaria | Phase 1 | Terminated(safety issues (toxi... 展开 >>city)) 收起 << | - | Australia, Victoria ... 展开 >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 收起 << |
NCT00115830 | Atherosclerosis | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00978419 | - | Completed | - | - | |
NCT00978419 | Burns | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT00871351 | Primary Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00491530 | - | Completed | - | - | |
NCT00871351 | - | Completed | - | - | |
NCT03474562 | ASCVD Impaire... 展开 >>d Fasting Glucose Hypertension 收起 << | Phase 4 | Not yet recruiting | October 2019 | Korea, Republic of ... 展开 >> Dankook University Hospital Not yet recruiting Cheonan, Korea, Republic of CHA Bundang Medical Center Not yet recruiting Seongnam, Korea, Republic of Gangnam Severance Hospital Not yet recruiting Seoul, Korea, Republic of Severance Hospital Not yet recruiting Seoul, Korea, Republic of 收起 << |
NCT00781560 | - | Completed | - | China, Beijing ... 展开 >> Research Site Beijing, Beijing, China China, Guangdong Research Site Chenzhen, Guangdong, China Research Site Guangzhou, Guangdong, China China, Heilongjiang Research Site Harbin, Heilongjiang, China China, Henan Research Site ZhengZhou, Henan, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Liaoning Research Site Shenyang, Liaoning, China China, Shandong Research Site Jinan, Shandong, China Research Site Qingdao, Shandong, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Xi'an, Shanxi, China China, Sichuan Research Site Chengdu, Sichuan, China China, Tianjin Research Site Tianjin, Tianjin, China China, Zhejiang Research Site Hangzhou, Zhejiang, China Reseearch Site Ningbo, Zhejiang, China 收起 << | |
NCT00468923 | Cardiovascular Disease ... 展开 >> Stroke 收起 << | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> Hamilton General Hospital Hamilton, Ontario, Canada, L8L 2X2 收起 << |
NCT03113994 | Spinal Cord Injuries ... 展开 >> Osteoporosis Metabolic Syndrome 收起 << | Phase 2 | Recruiting | December 2020 | United States, Florida ... 展开 >> University Of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Luisa Betancourt, MD, MS 305-243-6320 lbetancourt@med.miami.edu Principal Investigator: Mark S Nash, Ph.D., FACSM Canada, Ontario University Health Network - Toronto Rehab Lyndhurst Centre Recruiting Toronto, Ontario, Canada, M4G 3V9 Contact: Masae Miyatani, PhD 416-597-3422 ext 6304 masae.miyatani@uhn.ca Contact: Lindsie Blencowe, MSc 416-597-3422 ext 6301 lindsie.blencowe@uhn.ca Principal Investigator: Cathy Craven, BA, MD, MSc, FRCPC, CCD 收起 << |
NCT02665832 | Healthy | Phase 1 | Unknown | June 2016 | - |
NCT01567826 | Coronary Artery Disease | Phase 4 | Completed | - | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << |
NCT01567826 | - | Completed | - | - | |
NCT00681395 | Adverse Events ... 展开 >> Pharmacokinetic 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Site Reference ID/Investigator# 8089 Orlando, Florida, United States, 32809 收起 << |
NCT03536598 | Hypertension With Hyperlipidem... 展开 >>ia 收起 << | Phase 3 | Completed | - | - |
NCT03738761 | Hypertension | Phase 4 | Recruiting | April 2019 | Armenia ... 展开 >> Unimed medical center Not yet recruiting Abovyan, Armenia Center of Preventive Cardiology Not yet recruiting Yerevan, Armenia Croatia Thalassotherapia Opatija, Specijalna bolnica za medicinsku rehabilitaciju, bolesti srca, pluća i reumatizma, Klinika za liječenje, rehabilitaciju i prevenciju bolesti srca i krvnih žila Recruiting Opatija, Croatia KBC Rijeka - Sušak, Klinika za internu medicinu, Zavod za nefrologiju, dijalizu i transplantaciju bubrega Recruiting RIjeka, Croatia KB Dubrava, Klinika za unutarnje bolesti, Zavod za nefrologiju i dijalizu Recruiting Zagreb, Croatia KB Merkur, Klinika za unutarnje bolesti, Zavod za kardiologiju Recruiting Zagreb, Croatia KBC Sestre milosrdnice, Klinika za bolesti srca i krvnih žila, Zavod za bolesti krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za bolesti srca i krvnih žila Recruiting Zagreb, Croatia KBC Zagreb, Klinika za unutarnje bolesti, Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju Recruiting Zagreb, Croatia Poliklinika za prevenciju kardiovaskularnih bolesti i rehabilitaciju SRČANA Recruiting Zagreb, Croatia Hungary Biatros Kft. Recruiting Biatorbágy, Hungary AD SANITATEM Bt. Recruiting Pilisvörösvár, Hungary Poland Przychodnia Kardiologiczna w Zespole Przychodni Specjalistycznych DIAB-END-COR Active, not recruiting Krakow, Poland Niepubliczny Zakład Opieki Zdrowotnej Neuromed M.i M. Nastaj Spółka Partnerska Recruiting Lublin, Poland Poradnia Kardiologiczna, Nowodworskie Centrum Medyczne Active, not recruiting Nowy Dwór Mazowiecki, Poland Poradnia Kardiologiczna Samodzielnego Publicznego Zespołu Zakładów Opieki Zdrowotnej im. Marszałka Józefa Piłsudskiego w Płońsku Active, not recruiting Płońsk, Poland Poradnia Kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej Euro-Klinika Sp. z o.o. w Siemianowicach Śląskich Active, not recruiting Siemianowice Śląskie, Poland Poradnia internistyczno-kardiologiczna w Niepublicznym Zakładzie Opieki Zdrowotnej AURUM Active, not recruiting Warsaw, Poland Poradnia Kardiologiczna w Przychodni Rejonowej - Specjalistycznej (III) Samodzielnego Zespołu Publicznych Zakładów Lecznictwa Otwartego Warszawa - Ochota Recruiting Warsaw, Poland Przychodnia ACTIV-MED. Recruiting Warsaw, Poland Russian Federation Federal State Budgetary Scientific Institution "Scientific Research Institute of Complex Problems of Cardiovascular Diseases" Recruiting Kemerovo, Russian Federation Federal State budget organization National medical research center of cardiology of the Ministry of healthcare of the Russian Federation Recruiting Moscow, Russian Federation State Budgetary Institution of Healthcare of Moscow "City Clinical Hospital № 29 named after N.E. Bauman of Department of Healthcare of Moscow city" (SBIH "CCH № 29 Bauman") Not yet recruiting Moscow, Russian Federation Federal State Budgetary Institution "V.A. Almazov National Medical Research Center" of the Ministry of Health of the Russian Federation (V.A. Almazov NMRC) Recruiting Saint Petersburg, Russian Federation Federal State Budgetary Educational Institution Higher Education "Volgograd State Medical University" of the Ministry of Healthcare of the Russian Federation (FSBEI HE VolgSMU MOH Russia) Not yet recruiting Volgograd, Russian Federation Serbia Klinički centar Srbije Recruiting Belgrade, Serbia Klinički centar Niš Recruiting Niš, Serbia Inštitut za kardiovaskularne bolesti Vojvodine Recruiting Sremska Kamenica, Serbia Slovenia Univerzitetna klinika za pljučne bolezni in alergijo Golnik Recruiting Golnik, Slovenia Splošna bolnišnica Jesenice Recruiting Jesenice, Slovenia Zdravstveni Zavod CELJENJE Recruiting Koper, Slovenia Ordinacija interne medicine Verboten Kopriva Renata Recruiting Litija, Slovenia Cardial, d. o. o. Recruiting Ljubljana, Slovenia MC Medicor, d. d. Recruiting Ljubljana, Slovenia Intermed, d. o. o. Recruiting Maribor, Slovenia Srce in ožilje, d. o. o. Recruiting Maribor, Slovenia 收起 << |
NCT01644188 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01023503 | - | Withdrawn(Changes affecting Po... 展开 >>st Authorization Study Regulatory effective from Dec09, impacted the requirements for Spanish studies at National and Regional level.) 收起 << | July 2012 | Spain ... 展开 >> Research Site Barcelona, Spain 收起 << | |
NCT01563731 | Stroke Transi... 展开 >>ent Ischemic Attack Hypertension 收起 << | Phase 4 | Recruiting | November 2018 | Russian Federation ... 展开 >> Almazov Federal Heart, Blood and Endocrinology Centre Recruiting Saint-Petersburg, Russian Federation, 197341 收起 << |
NCT00256750 | - | Completed | - | - | |
NCT01890967 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT01047683 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT01890967 | - | Completed | - | - | |
NCT00256750 | Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 << | Phase 3 | Completed | - | - |
NCT01047501 | Hypertriglyceridemia | Phase 3 | Completed | - | - |
NCT01455935 | Stroke | Phase 2 | Unknown | February 2014 | United States, New York ... 展开 >> Millard Fillmore Gates Circle Hospital Recruiting Buffalo, New York, United States, 14209 Contact: Annemarie Crumlish 716-887-5548 acrumlish@thejni.org Principal Investigator: Tareq Kass-Hout, MD Principal Investigator: Elad Levy, MD Sub-Investigator: Adnan H Siddiqui, MD,PhD Sub-Investigator: Kenneth V Snyder, MD, PhD Sub-Investigator: L N Hopkins, MD Sub-Investigator: Robert N Sawyer, MD Sub-Investigator: Marilou Ching, MD Sub-Investigator: David Janicke, MD 收起 << |
NCT00132717 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02107898 | Hypercholesterolemia | Phase 3 | Completed | - | Japan ... 展开 >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan 收起 << |
NCT01644188 | - | Completed | - | - | |
NCT01492361 | Cardiovascular Diseases | Phase 3 | Completed | - | - |
NCT01507831 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02107898 | - | Completed | - | - | |
NCT01507831 | - | Completed | - | - | |
NCT01617655 | - | Completed | - | - | |
NCT02072161 | Hypercholesterolemia | Phase 2 | Completed | - | - |
NCT01617655 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT01644175 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02289963 | Hypercholesterolemia | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Investigational Site Number 410009 Anyang-Si, Korea, Republic of, 431-070 Investigational Site Number 410001 Anyang, Korea, Republic of, 431-070 Investigational Site Number 410017 Busan, Korea, Republic of, 602-715 Investigational Site Number 410007 Busan, Korea, Republic of, 614-735 Investigational Site Number 410002 Daegu, Korea, Republic of, 700-712 Investigational Site Number 410011 Goyang-Si, Korea, Republic of, 410-773 Investigational Site Number 410003 Gwangju, Korea, Republic of, 501-757 Investigational Site Number 410012 Incheon, Korea, Republic of, 405-760 Investigational Site Number 410018 Jeonju-Si, Korea, Republic of, 561-712 Investigational Site Number 410006 Seoul, Korea, Republic of, 06591 Investigational Site Number 410004 Seoul, Korea, Republic of, 07061 Investigational Site Number 410015 Seoul, Korea, Republic of, 08308 Investigational Site Number 410008 Seoul, Korea, Republic of, 110-746 Investigational Site Number 410005 Seoul, Korea, Republic of, 134-727 Investigational Site Number 410010 Seoul, Korea, Republic of, 152-703 Investigational Site Number 410013 Ulsan, Korea, Republic of Taiwan Investigational Site Number 158007 Changhua, Taiwan, 500 Investigational Site Number 158005 Hsinchu, Taiwan, 30071 Investigational Site Number 158011 Kaohsiung, Taiwan, 807 Investigational Site Number 158010 Kaohsiung, Taiwan, 833 Investigational Site Number 158006 Taichung, Taiwan Investigational Site Number 158009 Tainan Hsien, Taiwan, 710 Investigational Site Number 158008 Tainan, Taiwan, 704 Investigational Site Number 158001 Taipei, Taiwan, 100 Investigational Site Number 158003 Taipei, Taiwan, 104 Investigational Site Number 158002 Taipei, Taiwan, 112 Investigational Site Number 158004 Taoyuan Hsien, Taiwan 收起 << |
NCT01623115 | - | Completed | - | - | |
NCT02289963 | - | Completed | - | - | |
NCT01623115 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00812955 | Dyslipidemia, Hypercholesterol... 展开 >>emia, Hypertriglyceridemia 收起 << | Phase 3 | Completed | - | - |
NCT03510715 | Hypercholesterolemia | Phase 3 | Recruiting | June 2020 | United States, California ... 展开 >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 收起 << |
NCT03510884 | Hypercholesterolaemia | Phase 3 | Recruiting | March 2022 | - |
NCT01926782 | - | Completed | - | - | |
NCT00532311 | Hypercholesterolemia | Phase 3 | Terminated(Overall profile of ... 展开 >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) 收起 << | - | - |
NCT01644175 | - | Completed | - | - | |
NCT03061487 | - | Recruiting | April 27, 2018 | Italy ... 展开 >> University Magna Graecia of Catanzaro Recruiting Catanzaro, Italy, 88100 Contact: Raffaele Serra, M.D., Ph.D. +3909613647380 rserra@unicz.it Sub-Investigator: Stefano de Franciscis, M.D. Sub-Investigator: Luca Gallelli, M.D.; Ph.D 收起 << | |
NCT00812955 | - | Completed | - | - | |
NCT01259791 | Statin Myopathy | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> St. Joseph's Health Care London, Ontario, Canada, N6A 4V2 收起 << |
NCT01926782 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02386917 | Obesity | Not Applicable | Active, not recruiting | December 2019 | Norway ... 展开 >> HVestfold Tønsberg, Vestfold, Norway, 3103 收起 << |
NCT00359281 | Healthy | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT02551172 | Hyperlipidemias | Phase 3 | Unknown | February 2016 | Korea, Republic of ... 展开 >> Euljii General Hospital Recruiting Seoul, Korea, Republic of, 139-711 Contact: Jin-Young Jang +82-2-970-8216 erica_37@naver.com Principal Investigator: Kyung Ah Han, M.D., Ph.D. 收起 << |
NCT01954394 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00079638 | Dyslipidemia ... 展开 >>Coronary Heart Disease Atherosclerosis Stroke Diabetes 收起 << | Phase 4 | Completed | - | - |
NCT00673660 | - | Completed | - | Turkey ... 展开 >> Pfizer Investigational Site Mecidiyekoy, Istanbul, Turkey, 34394 Pfizer Investigational Site Bolu, Turkey Pfizer Investigational Site Haseki/Istanbul, Turkey, 34390 Pfizer Investigational Site Istanbul, Turkey, 34098 Pfizer Investigational Site Istanbul, Turkey 收起 << | |
NCT01954394 | - | Completed | - | - | |
NCT01702987 | Myopathy HMG ... 展开 >>COA Reductase Inhibitor Adverse Reaction Hypercholesterolemia 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT00673660 | - | Completed | - | - | |
NCT03267329 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 4 | Not yet recruiting | October 2018 | Korea, Republic of ... 展开 >> The Catholic University of Korea, Bucheon ST. Mary's Hospital Bucheon-si, Korea, Republic of Inje University Ilsan PAIK Hospital Goyang-si, Korea, Republic of KangBuk Samsung Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Yonsei University Health System, SEVERANCE HOSPITAL Seoul, Korea, Republic of Seoul National University, Bundang Hospital Sŏngnam, Korea, Republic of Wonju Severance Christian Hospital Wŏnju, Korea, Republic of 收起 << |
NCT02976818 | - | Recruiting | April 2019 | Canada ... 展开 >> Institute of Nutrition and Functional Foods (INAF) Recruiting Quebec, Canada, G1V 0A6 Contact: Patrick Couture, MD, FRCP,PhD 418-654-2106 patrick.couture@crchul.ulaval.ca Contact: André Tremblay, PhD 418-656-2131 ext 11417 andre.tremblay@fsaa.ulaval.ca Principal Investigator: Patrick Couture, MD,FRCP,PhD Sub-Investigator: André Tremblay, PhD 收起 << | |
NCT01702987 | - | Completed | - | - | |
NCT01972178 | Dyslipidemia | Phase 2 | Terminated | - | - |
NCT03127631 | Prostate Cancer ... 展开 >> Cardiovascular Disease 收起 << | Not Applicable | Recruiting | September 2020 | Canada, British Columbia ... 展开 >> Vancouver General Hospital Active, not recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario William Osler Health System Recruiting Brampton, Ontario, Canada, L6R 3J7 Contact: Achal Sharma achal.sharma@williamoslerhs.ca Principal Investigator: Dr. Tamara Wallington, MD,FRCPC St. Joseph's Healthcare Recruiting Hamilton, Ontario, Canada, L8N4A6 Contact: Aishwarya Sudakaran sudakaran@hhsc.ca Principal Investigator: Dr. Bobby Shayegan, MD,FRCSC Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V1C3 Contact: Amanda Thiessen thiessena@hhsc.ca Principal Investigator: Dr. Jehonathan Pinthus, MD,FRCS(C),PhD Queen's University Recruiting Kingston, Ontario, Canada, K7L 3J7 Contact: Wendy Anstey, RN wendy.anstey@krcc.on.ca Principal Investigator: Dr. Robert Siemens, MD,FRCSC Grand River Hospital, Grand River Regional Cancer Centre Recruiting Kitchener, Ontario, Canada, N2G 1G3 Contact: Elyse Wellhauser Elyse.Wellhauser@grhosp.on.ca Principal Investigator: Darin Gopaul, MD London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mounirah May mounirah.may@lhsc.ca Principal Investigator: Dr. Patrick Luke, MD,FRCSC London Health Sciences, Victoria Hospital Recruiting London, Ontario, Canada, N6A 5W9 Contact: Amanda Anderson Amanda.Anderson@lhsc.on.ca Principal Investigator: Joseph Chin, MD, FRCSC Niagara Health, St. Catharines Site Active, not recruiting Niagara, Ontario, Canada, L2S 0A9 Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Knee, ND, MSc cknee@ohri.ca Principal Investigator: Dr. Luke Lavallee, MDCM,MSc,FRCSC Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Marlene Kebabdjian marlene.kebabdjian@sunnybrook.ca Principal Investigator: Dr. Laurence Klotz, MD,FRCS(C) University Health Network, Princess Margaret Cancer Centre Active, not recruiting Toronto, Ontario, Canada, M5G 2C1 Canada, Quebec University Hospital of Montreal Recruiting Montreal, Quebec, Canada, H2X 0A9 Contact: Roberta Carling roberta-daila.carling.chum@ssss.gouv.qc.ca Principal Investigator: Dr. Emmanuelle Duceppe, MD,FRCPC Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Amandine Laffitte amandine.laffitte.ccomtl@ssss.gouv.qc.ca Principal Investigator: Dr. Tamim Niazi, MDCM McGill University Active, not recruiting Montréal, Quebec, Canada, H3A 0G4 Laval University Recruiting Quebec City, Quebec, Canada, G1V 0A6 Contact: Denise St-Onge denise.st-onge@crchudequebec.ulaval.ca Principal Investigator: Dr. Vincent Fradet, MD,PhD,FRCSC 收起 << |
NCT01444326 | Cardiovascular Disease | Not Applicable | Completed | - | Canada ... 展开 >> Institute of Nutraceutical and Functional Foods (INAF), Laval University Quebec, Canada, G1V 0A6 收起 << |
NCT01436123 | Coronary Artery Disease ... 展开 >> Atherosclerosis 收起 << | Phase 1 | Terminated(The study was termi... 展开 >>nated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology) 收起 << | - | Netherlands ... 展开 >> De Haar Research Foundation Rotterdam, South Holland, Netherlands, 3071PR Russian Federation Ural Center of Modern Nanotechnologies, Institute of Natural Sciences, Ural Federal University Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620000 Ural Institute of Cardiology Yekaterinburg, Sverdlovsk oblast, Russian Federation, 620144 收起 << |
NCT00359281 | - | Completed | - | - | |
NCT00360217 | Hypertriglyceridemia (TG>200<5... 展开 >>00) Hyperlipidemia Coronary Artery Disease Coronary Risk Equivalent Diabetes 收起 << | Not Applicable | Completed | - | United States, Maine ... 展开 >> Maine Center for Lipids and Cardiovascular Health Scarborough, Maine, United States, 04074 收起 << |
NCT03533959 | - | Recruiting | December 2025 | Japan ... 展开 >> Kobe University Graduate School of Medicine, Department of Cardiology Recruiting Kobe, Hyogo, Japan, 650-0017 Contact: Hiromasa Otake, MD +81783825846 hotake@med.kobe-u.ac.jp 收起 << | |
NCT00261352 | Type 2 Diabetes | Phase 3 | Terminated(The development pro... 展开 >>gram has been terminated) 收起 << | - | - |
NCT03121521 | Hepatopathy | Phase 4 | Completed | - | - |
NCT01274559 | Primary Hypercholesterolemia ... 展开 >> Mixed Dyslipidemia 收起 << | Phase 3 | Terminated(In HPS2-THRIVE, MK-... 展开 >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) 收起 << | - | - |
NCT01274559 | - | Terminated(In HPS2-THRIVE, MK-... 展开 >>0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs) 收起 << | - | - | |
NCT01257971 | - | Completed | - | Croatia ... 展开 >> Research Site Biograd na moru, Croatia Research Site Bjelovar, Croatia Research Site Cakovec, Croatia Research Site Crikvenica, Croatia Research Site Dubrovnik, Croatia Research Site Gospic, Croatia Research Site Karlovac, Croatia Research Site Koprivnica, Croatia Research Site Krapina, Croatia Research Site Krapinske toplice, Croatia Research Site Opatija, Croatia Research Site Osijek, Croatia Research Site Porec, Croatia Research Site Pula, Croatia Research Site Rijeka, Croatia Research Site Sisak, Croatia Research Site Slavonski brod, Croatia Research Site Split, Croatia Research Site Stubicke toplice, Croatia Research Site Umag, Croatia Research Site Vinkovci, Croatia Research Site Virovitica- Slatina, Croatia Research Site Virovitica, Croatia Research Site Vukovar, Croatia Research Site Zadar, Croatia Research Site Zageb, Croatia Research Site Zagreb, Croatia 收起 << | |
NCT00726362 | - | Completed | - | Taiwan ... 展开 >> Research Site Changhua, Taiwan Research Site Hualien, Taiwan Research Site Kaohsiung, Taiwan Research Site Pingtung, Taiwan Research Site Taichung, Taiwan Research Site Tainan, Taiwan Research Site Taipei, Taiwan Research Site Yun-Lin, Taiwan 收起 << | |
NCT01483950 | - | Completed | - | Bosnia and Herzegovina ... 展开 >> Research Site Banja Luka, Bosnia and Herzegovina Research Site Bijeljina, Bosnia and Herzegovina Research Site Doboj, Bosnia and Herzegovina Reserach Site Gradiška, Bosnia and Herzegovina Research Site Kakanj, Bosnia and Herzegovina Research Site Maglaj, Bosnia and Herzegovina Research Site Prijedor, Bosnia and Herzegovina Research Site Sarajevo, Bosnia and Herzegovina Research Site Tešanj, Bosnia and Herzegovina Research Site Trebinje, Bosnia and Herzegovina Research Site Visoko, Bosnia and Herzegovina Research Site Zavidovići, Bosnia and Herzegovina Research Site Zenica, Bosnia and Herzegovina Research Site Zvornik, Bosnia and Herzegovina 收起 << | |
NCT00125125 | Dyslipidemia | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Novartis East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany 收起 << |
NCT00127218 | Atherosclerosis ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Unversity School of Medicine Baltimore, Maryland, United States, 21218 收起 << |
NCT00127218 | - | Completed | - | - | |
NCT00251680 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02941848 | Primary Hypercholesterolemia | Phase 1 | Completed | - | - |
NCT03417388 | Coronary Artery Disease | Phase 4 | Recruiting | December 30, 2022 | United States, California ... 展开 >> Cedars-Sinai Heart Institute Recruiting Los Angeles, California, United States, 90048 Contact: Sophie Yoo, MS 310-423-3300 jihye.yoo@cshs.org Principal Investigator: Chrisandra Shufelt, MD LA BioMedical Recruiting Torrance, California, United States, 90502 Principal Investigator: Matthew Budoff, MD United States, Florida Family Medicine at Eastside Community Practice Recruiting Gainesville, Florida, United States, 32206 Family Medicine at Hampton Oaks Medical Plaza (Adults and Peds) Recruiting Gainesville, Florida, United States, 32607 Internal Medicine at Tower Hill Recruiting Gainesville, Florida, United States, 32607 Family Medicine at Haile Plantation (Adults & Peds) Recruiting Gainesville, Florida, United States, 32608 Cardiovascular Clinic at UF Health UF Recruiting Gainesville, Florida, United States, 32610 Internal Medicine at UF Health Medical Plaza Recruiting Gainesville, Florida, United States, 32610 UF Health at the University of Florida Recruiting Gainesville, Florida, United States, 32610 Cardiology West at Doctors Park Recruiting Gainesville, Florida, United States, 32611 Family Medicine at 4th Ave Recruiting Gainesville, Florida, United States, 32611 Family Medicine at Old Town (Adults and Peds) Recruiting Gainesville, Florida, United States, 32680 Baptist Health Recruiting Jacksonville, Florida, United States, 32207 Principal Investigator: Ruple Galani, MD Naval Hospital Jacksonville Recruiting Jacksonville, Florida, United States, 32214 UF Primary Care at Lake City SW Recruiting Lake City, Florida, United States, 32024 UF Primary Care at Lake City West Recruiting Lake City, Florida, United States, 32024 Novel Clinical Research Recruiting Miami, Florida, United States, 33186 Contact: Heber L Varela, MD 786-773-2737 Daytona Heart Group Recruiting Multiple Locations, Florida, United States, 32114 Contact: Glenn Rayos, MD 386-258-8722 Ocala Research Institute Inc. Recruiting Ocala, Florida, United States, 34480 Contact: Rakesh Prashad, MD 352-412-5989 Orlando Health Recruiting Orlando, Florida, United States, 32806 Principal Investigator: Arnold Einhorn, MD Naval Hospital Pensacola Recruiting Pensacola, Florida, United States, 32512 Principal Investigator: Carrie Gray, MD Florida Hospital Tampa - Pepin Heart Institute Recruiting Tampa, Florida, United States, 33613 Contact: Charles R Lambert, MD 813-615-7527 Interventional Cardiac Consultants Recruiting Tampa, Florida, United States, 33613 Contact: Carlos J Bayron, MD 727-842-9526 United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40506 Principal Investigator: Gretchen Wells, MD 收起 << |
NCT01970215 | Dyslipidemia | Phase 2 | Completed | - | Denmark ... 展开 >> H:S Amager Hospital Copenhagen, Denmark Sydvestjysk Sygehus Esbjerg, Denmark Herlev University Hospital Herlev, Denmark Hvidovre Hospital Hvidovre, Denmark Regionshopitalet - Silkeborg Silkeborg, Denmark Netherlands EB FlevoResearch B.V Almere, Netherlands Academic Medical Centre Amsterdam-Zuidoost, Netherlands Andromed Amsterdam Amsterdam, Netherlands Andromed Leiden Amsterdam, Netherlands Andromed Breda B.V Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord B.V Groningen, Netherlands Andromed Zoetermeer Leiderdorp, Netherlands Andromed Rotterdam BV Rotterdam, Netherlands Albert Schweitzer Ziekenhuis Sliedrecht, Netherlands Andromed Oost Velp, Netherlands Praktijk Zwijndrecht Zwijndrecht, Netherlands 收起 << |
NCT02941796 | Hyperlipidemias | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Inje University Busan Paik Hospital Busan, Korea, Republic of 收起 << |
NCT00309374 | Endotoxemia | Phase 1 | Completed | - | Austria ... 展开 >> Medical University of Vienna, Dept. of Clinical Pharmacology Vienna, Austria 收起 << |
NCT01709500 | Heterozygous Familial Hypercho... 展开 >>lesterolemia 收起 << | Phase 3 | Completed | - | Czech Republic ... 展开 >> Hradec Kralove, Czech Republic Praha 2, Czech Republic Praha 5, Czech Republic Praha 8, Czech Republic Trutnov, Czech Republic Vyskov, Czech Republic Netherlands Alkmaar, Netherlands Amsterdam, Netherlands Apeldoorn, Netherlands Enschede, Netherlands Goes, Netherlands Groningen, Netherlands Hoogeveen, Netherlands Hoorn, Netherlands Rotterdam, Netherlands Sittard- Geleen, Netherlands Utrecht (2 locations), Netherlands Venlo, Netherlands Waalwijk, Netherlands Norway Oslo, Norway United Kingdom Cardiff, United Kingdom London, United Kingdom Manchester, United Kingdom Middlesex, United Kingdom Newcastle upon Tyne, United Kingdom West Bromwich, United Kingdom 收起 << |
NCT00664469 | Hypercholesterolemia | Phase 3 | Terminated(Poor enrollment) | - | Canada, Quebec ... 展开 >> Merck Frosst Canada Ltd. Kirkland, Quebec, Canada, H9H 3L1 收起 << |
NCT01709500 | - | Completed | - | - | |
NCT02850081 | Carotid Artery Stenosis ... 展开 >> Strokes 收起 << | Phase 3 | Recruiting | April 2022 | United States, New Jersey ... 展开 >> Valley Hospital Not yet recruiting Ridgewood, New Jersey, United States, 07450 Contact: Avery Freed 201-389-0194 afreed@valleyhealth.com Contact: Kathleen Sayles KSAYLES@valleyhealth.com Principal Investigator: Dorothea Altschul, MD United States, New York Albany Medical College/The Vascular Group at Albany Not yet recruiting Albany, New York, United States, 12208-3479 Contact: Ryan Kaim KaimR@mail.amc.edu Contact: Angela Sheehan SheehaA@mail.amc.edu Principal Investigator: Courtney Warner, MD Sub-Investigator: Ralph C Darling, MD State University of New York at Buffalo Not yet recruiting Buffalo, New York, United States, 14260-7016 Contact: Jennifer Gay 716-440-4231 jgay@ubns.com Contact: Reagan O'Toole rotoole@ubns.com Principal Investigator: Adnan Siddiqui, MD New York University School of Medicine Not yet recruiting New York, New York, United States, 10016-6402 Contact: Jacqueline Bott 212-263-2268 jacqueline.bott@nyumc.org Principal Investigator: Thomas Maldonado, MD Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Rebecca Apruzzese 212-241-8349 rebecca.apruzzese@mountsinai.org Contact: Milerva Santos milerva.santos@mountsinai.org Principal Investigator: J Mocco, MD Sub-Investigator: Emilia Bagiella, MD Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Rebeca Aragon Garcia, BS 212-305-4679 ra2356@cumc.columbia.edu Contact: Josephine U Pucci, BA 21123054679 jup2102@cumc.columbia.edu Principal Investigator: Edward S Connolly, MD Sub-Investigator: Elise A Caccappolo Van Vliet, PhD Sub-Investigator: Yaakov Stern, MD Sub-Investigator: Richard Buchsbaum Sub-Investigator: Eric J Heyer, MD Sub-Investigator: Erin L Heinzen-Cox, PhD Cornell University Medical College (Weill) Not yet recruiting New York, New York, United States, 10065-4805 Contact: Ruchita Mehta rum2006@med.cornell.edu Principal Investigator: Peter Connolly, MD 收起 << |
NCT02715726 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00964106 | Drug Interactions | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> GSK Investigational Site Busan, Korea, Republic of, 614-735 GSK Investigational Site Seoul, Korea, Republic of, 110-744 收起 << |
NCT01763866 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT03648788 | - | Not yet recruiting | August 2024 | - | |
NCT02518516 | - | Completed | - | Canada, British Columbia ... 展开 >> Dept. of Anesthesiology, Pharmacology & Therapeutics (APT), University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 收起 << | |
NCT01763866 | - | Completed | - | - | |
NCT00249899 | Hypercholesterolemia | Phase 3 | Terminated(Overall profile of ... 展开 >>the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents) 收起 << | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!